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Abstract 
We explore in this research paper the concept of avoidable mortality and how the way it is measured 
has evolved over time. Starting from an earlier review by Nolte and McKee (2004), we review the 
empirical studies which have been produced since then. Finally we appraise the empirical 
DSSOLFDWLRQV RI WKH PRVW UHFHQW OLWHUDWXUH 7KH FRQFHSW RI ³DYRLGDEOH PRUWDOLW\´ UHIHUV EURDGO\
speaking, to all those deaths that, given current medical knowledge and technology, could be avoided 
by the healthcare system through either prevention and/or treatment.  It originates from the pioneering 
work by Rutstein, Berenberg et al. (1976) ZKLFK LQWURGXFHG WKH QRWLRQ RI µXQQHFHVVDU\ XQWLPHO\
GHDWKV¶DVDQHZZD\WRPHDVXULQJWKHTXDOLW\RIPHGLFDOFDUH 
The most recent empirical literature shows that the notion of avoidable mortality continues to be used 
to establish the extent to which people are dying from amenable conditions within and/or across 
countries and over time, and whether socio-economic status and ethnicity are related to mortality from 
amenable conditions.  Most studies use data taken from national death registries, with only two which 
link the concept of avoidable mortality to routinely collected administrative data of healthcare 
provision, such as hospitals. A number of criticisms are raised, with probably the most remarkable 
being the lack of association found between avoidable mortality and healthcare inputs. No study has 
actually attempted to use the concept of avoidable mortality within the original aim envisaged by 
Rutstein, i.e. as a quality indicator of healthcare provision.  
 
We recommend for future work in this area to focus on investigating the link between the provision of 
healthcare and the concept of avoidable mortality, with a particular emphasis on using routinely 
collected administrative data, such as hospital discharge data.  
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1. Introduction 
 
7KHFRQFHSWRI³DYRLGDEOHPRUWDOLW\´UHIHUVEURDGO\VSHDNLQJ WRDOO WKRVHGHDWKVWKDW, given current 
medical knowledge and technology, could be avoided by the healthcare system through either 
prevention and/or treatment.  It originates from the pioneering work by Rutstein, Berenberg et al. 
(1976) ZKLFKLQWURGXFHGWKHQRWLRQRIµXQQHFHVVDU\XQWLPHO\GHDWKV¶DVDQHZZD\WRPHDVXULQJWKH
quality of medical care (healthcare).  They proposed a list of 91 conditions ± µVHQWLQHOKHDOWKHYHQWV¶± 
IRU ZKLFK GHDWK VKRXOG QRW RFFXU LI µWLPHO\ DQG HIIHFWLYH¶ KHDOWKFDUH LV SURYLGHG $Q\ XQQHFHVVDU\
GLVHDVH GLVDELOLW\ RU XQQHFHVVDU\ XQWLPHO\ GHDWKV WKDW RFFXU IRU DQ\ µVHQWLQHO KHDOWK HYHQWV¶ is 
included in a negative index to measure the (poor) quality of healthcare and should be further 
investigated (Rutstein, Berenberg et al. 1976). 
 
A number of different lists of conditions
1
 has since been produced and updated over time.  Likewise, a 
considerable number of empirical studies have been implemented for various countries, socio-
economic groups and time periods. 
 
The goals of this paper are (1) to describe the concept of avoidable mortality and the evolution of the 
way it has been measured along with the most recent criticisms, (2) to review the empirical studies 
which have been produced since year 2004, updating the earlier review by Nolte and McKee (2004) 
and (3) to appraise the recent empirical applications.  
  
                                                          
1 Charlton, Hartley et al. 1983; Poikolainen and Eskola 1986; Mackenbach, Kunst et al. 1988; Mackenbach, Looman et al. 
1988; Mackenbach, Looman et al. 1988; Poikolainen and Eskola 1988; Mackenbach 1991; Westerling 1992; Westerling 1993; 
Westerling 1996a; Westerling 1996b; Simonato, Ballard et al. 1998; Tobias and Jackson 2001; Nolte and McKee 2004; Page, 
Tobias et al. 2006 
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2. The concept of avoidable mortality 
 
2.1 Health production process and avoidable mortality 
 
Figure 1 describes the health production process and introduces the concept of avoidable mortality.  
Public Health programs and policies may have an impact on parental investments in health and 
education, but also may have an influence through the education of an individual, mass-media and 
environmental factors, as well as directly.  All these factors along with the overall population health 
DQGLQGLYLGXDOKHDOWKHQGRZPHQWDWELUWKSOD\DUROHLQWKHIRUPDWLRQRIDQLQGLYLGXDO¶VKHDOWKEHOLHIV
health behaviour and level of concern about health.  Given these characteristics and the availability 
and costs of preventive and screening technology, an individual decides whether to engage in 
preventive behaviour and/or undergo screening and early diagnostics.  Two outcomes are possible at 
this stage ± HLWKHU³JRRGKHDOWK´RUFRQWUDFWLRQRID³GLVHDVH´,IWKHFRQWUDFWHGGLVHDVHLVFODVVLILHG
DV³DPHQDEOHWRKHDOWKSROLF\´ WKHQDGHDWKIURPWKLVFRQGLWLRQ LVFRQVLGHUHG³DYRLGDEOH´QRPDWWHU
ZKHWKHU WKHFRQGLWLRQ LV³DPHQDEOHWRPHGLFDOFDUH´RUQRW $PRQJWKHFRQGLtions which cannot be 
SUHYHQWHGWKURXJKKHDOWKSROLFLHVDUHVRPHZKLFKFDQEHVXFFHVVIXOO\WUHDWHG³DPHQDEOHWRPHGLFDO
FDUH´  $ GHDWK IURP RQH RI VXFK FRQGLWLRQV LV DOVR FRQVLGHUHG ³DYRLGDEOH´  2QO\ D GHDWK IURP
conditions which neither could be prevented nor treated is thought to be unavoidable and should not 
be viewed as reflective of the quality of a healthcare system. 
 
7KHFRQFHSWRIµDYRLGDEOHPRUWDOLW\¶DQGLWVHYROXWLRQRYHUWLPH 
 
The first studies that concerned themselves with the concept RIWKHµDYRLGDELOLW\¶RIGHDWKVGDWHEDFN
to the early 20
th
 FHQWXU\ZKHQFDVHVRIPDWHUQDOGHDWKVZHUHLQYHVWLJDWHGDVµFRQILGHQWLDOHQTXLULHV¶
in the UK (MacFarlane 2004) and later in the USA, with the New York Academy of Medicine 
investigating maternal deaths in New York City.  These investigations are believed to have played an 
important role in saving maternal lives (Holland 2009). 
 
However, it was only in the 70s that a thorough investigation into the causes of deaths was carried out 
by a group of researchers based in the United States and led by Rutstein (1976).  Experts from 
medicine, epidemiology, public health and related fields worked together to identify a number of 
conditions for which death or disability should not occur if timely and effective medical care is 
DGPLQLVWHUHG  7KH JURXS VXJJHVWHG WKDW DQ\ µXQQHFHVVDU\ GLVHDVH RU GLVDELOLW\ DQG XQQHFHVVDU\
XQWLPHO\GHDWK¶ WKDWRFFXUV LQ WKHVHFRQGLWLRQVVKRXOGVHUYHDVDZDUQLQJVLJQDOD ³VHQWLQHOKHDOWK
HYHQW´RIWKHSRRUTXDOLW\RIKHDOWKFDUHUeceived.  Three separate sets of conditions were identified.  
7KHILUVWVHWLQFOXGHGFRQGLWLRQVZKLFKZHUHLGHQWLILHGDV³FOHDU-FXWLPPHGLDWHXVH´LQGLFHVRIWKH
TXDOLW\RIKHDOWKFDUHDQGKDYHEHHQUHIHUUHGWRDV³VLQJOH-FDVHLQGH[HV´(Carr, Szapiro et al. 1989).  It 
was suggested that even one case of death within this list should be thoroughly investigated.  The 
VHFRQGVHWRIFRQGLWLRQVZDVLGHQWLILHGDV³OLPLWHGXVH´IRUZKLFKDQXPEHURIGHDWKVUDWKHUWKDQD
single event) should justify further inYHVWLJDWLRQ7KHVHDUHDOVRNQRZQDV³LQGH[HVEDVHGRQUDWHV´
(Carr, Szapiro et al. 1989).  The third set included medico-social problems, which Rutstein and 
colleagues identified as the set demanding further work and clarification given that the medical 
knowledge of the time did not allow determining with certainty the contributions that healthcare could 
PDNHLQDYRLGLQJGHDWKVIURPWKHVHFRQGLWLRQV5XWVWHLQ¶VRULJLQDOOLVWZDVEDVHGRQYHUVLRQRIWKH
International Classification of Disease coding system. 
 
5XWVWHLQ¶V RULJLQDO OLVW RI XQWLPHO\ GLVHDVH GLVDELOLW\ DQG GHDWK ZDV UHYLVHG LQ  (Rutstein, 
Berenberg et al.) and 1980 (Rutstein, Berenberg et al.) to take into account advances in medical care 
as well as to incorporate changes made to the ICD codes (9
th
 revision).  The origin of the term 
avoidable mortality is due, however, to Charlton et al. (1983), who first introduced it in their study of 
regional variation in mortality in England and Wales.  The concept was later broadened to include 
µSUHYHQWDEOHFDXVHV¶RIGHDWKVDQG WKHVHSDUDWH WHUP µDPHQDEOHPRUWDOLW\¶ZDV LQWURGXFHG (Holland 
1988; Simonato, Ballard et al. 1998; Tobias and Jackson 2001).  OveU WLPH WKH ZRUGV µDPHQDEOH¶
µDYRLGDEOH¶ DQG µXQQHFHVVDU\ FDXVHV RI GHDWK¶ KDYH EHHQ XVHG LQWHUFKDQJHDEO\  +RZHYHU PRUH
precise definitions have emerged, which distinguish between them (Nolte, Scholz et al. 2004; Wheller, 
Baker et al. 2007; Macinko and Elo 2009), although some authors still use the terms amenable and 
avoidable interchangeably (Kossarova, Holland et al. 2009).  See Box 1 for a summary.  
 
  
Avoidable mortality: what it means and how it is measured  3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Individual and healthcare factors and avoidability of death 
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The concept of avoidable mortality refers, therefore, to all those deaths that, given current medical 
knowledge and technology, could be avoided by the healthcare system through either prevention 
and/or treatment.  It follows clearly that the selection of conditions/diseases that are amenable to both 
healthcare treatment and prevention depends on the particular circumstances of any given country at 
any given point in time.  Some of the deaths which are considered avoidable today in a developed 
country, half a century ago might well have been unavoidable (Dahl, Hofoss et al. 2007).  Likewise, 
given the state of healthcare systems in the developing nations, many of the diseases for which the 
cure exists somewhere may be yet unavailable in this particular country.  If the goal is to compare 
various countries and produce ranking of the healthcare systems using avoidable mortality as a 
measure of quality of service, this definition then might be problematic.  The thing is that nowadays in 
the era of globalization and openness most technologies, especially health-related, are tradable.  
Therefore, what constrains less developed countries from using superior technologies is lack of 
UHVRXUFHVRUUHJXODWRU\GHILFLHQFLHVQRWWKHWHFKQRORJLHV¶DYDLODELOLW\(Tang, Petrie et al. 2009).  
 
Rutstein et al. (1976) adopted the broadest definition of medical care, identifying 91 conditions leading 
to unnecessary untimely deaths.  Charlton et al. (1983) narrowed the scope to medical interventions 
only, excluding conditions which depended mainly on prevention (e.g. lung cancer).  They also set 
age limits for each condition, whilst excluding some conditions for which there were fewer than 200 
deaths within the 5-year age groups in England and Wales.  They identified 14 disease groups.  The 
exclusion restrictions were justified by the fact that the authors analysed the conditions separately at 
the level of Area Health Authorities.  Some later studies (Mackenbach, Looman et al. 1988; Schwartz, 
Kofie et al. 1990; Wood, Sallar et al. 1999) DOVRXVHG&KDUOWRQHWDO¶VOLVW(1983) without questioning 
the inclusion criteria.   
 
Poikolainen and Eskola (1986; 1988) DOVREDVHGWKHLUOLVWRIFRQGLWLRQVRQ5XWVWHLQ¶VOLVWEXWH[FOXGHG
one condition, which they thought to be outside the control of health services in Finland, and grouped 
WKHUHPDLQLQJRQHVLQWRµDPHQDEOH¶FRQGLWLRQVDQGµSDUWO\DPHQDEOH¶FRQGLWLRQV 
 
Holland et al. (1988; 1991; 1997) in their compilation of the European Community Atlas of Avoidable 
Deaths adopted the concept of avoidable mortality using as a starting point the work by Charlton et al. 
(1983).  They identified 17 disease groups, considered to be either preventable or treatable by 
healthcare services.  They also introduced  age limits (5 to 64)  for most conditions with the exception 
of measles and respiratory disease (1-14), tetanus (0-64), cancer of cervix uteri and cirrhosis of liver 
(15-64), whooping cough (0-14), osteomyelitis (1-64), and maternal conditions (no age limit). 
 
Westerling and others (Westerling 1992; Westerling 1993; Westerling, Gullberg et al. 1996) were the 
first to introduce explicit comparisons of preventable versus treatable conditions, whilst Simonato et 
al. (1998) started differentiating between mortality amenable to primary prevention, early detection 
and treatment, and mortality amenable to improved treatment and medical care.  Tobias and Jackson 
(2001) broadened the list of conditions substantially by reviewing the literature on medical advances 
since 1980s.  They also increased the age limit to 75, and assigned relative weights to primary, 
secondary and tertiary prevention.  However, this latter approach has not been followed in 
subsequent studies.  The most influential methodological studies involved either consultations with 
experts from various fields of medicine, a systematic review of the relevant literature to update the list 
according to the most recent medical advances (Nolte and McKee 2004) or both (Page, Tobias et al. 
Box 1 
Avoidable mortality: causes of deaths that are considered amenable to both 
medical intervention and health policy. 
Treatable causes or medical care indicators (MCI): causes of deaths 
amenable to medical intervention only. 
Preventable causes or health policy indicators (HPI): causes of death that 
are amenable to health policy only. 
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2006)
2
.  Unfortunately, none of them provides a description of the methodology followed in the 
consultations and the criteria used to eventually reach an agreement in the event of differences in 
opinions.  The only exception is the work by Page, Tobias et al. (2006) where the authors provide the 
rationale for including various causes into the list. 
 
The variety of approaches to defining and identifying causes of death that are avoidable poses a 
QXPEHURIFKDOOHQJHVDVSDWWHUQVDQGWUHQGVRI³DYRLGDEOHPRUWDOLW\FDQEHYHU\VHQVLWLYHWRWKHXVH
of different lists of causes of deaths (French and Jones 2006).  The following table shows these 
differences by using the study by French and Jones (2006).  The authors consider geographical 
WUHQGVLQPRUWDOLW\RYHUWKHSHULRGIURPWRLQ*UHDW%ULWDLQXVLQJERWK&KDUOWRQ¶VHWDO¶VOLVW
(1983) and HollDQG¶VOLVWV(1988).  They find that both average trends and spatial patterns vary greatly 
EHWZHHQWKHWZROLVWV6LQFHWKH+ROODQG¶VOLVWLVORQJHULWFODVVLILHVDKLJKHUSURSRUWLRQRIGHDWKVDV
µDYRLGDEOH¶± FRPSDUHGWRIROORZLQJWKH&KDUOWRQ¶VOist. Table 1 summarizes the difference in 
the lists and major findings. 
 
An entirely different approach to the measurement of avoidable mortality worth mentioning is the one 
adopted by a group of researchers from Australia (Tang, Chin et al. 2008; Petrie, Tang et al. 
2009;Tang, Petrie et al. 2009).  They consider the world population as a whole and identify for each 
age-gender group the country with the lowest risk of mortality in that particular age-gender group.  
This risk of mortality is then considered as the level of mortality that is unavoidable.  In this way they 
FRQVWUXFW DQ XQDYRLGDEOH ULVN SURILOH IRU DOO DJH DQG JHQGHU JURXSV IRU D K\SRWKHWLFDO µUHIHUHQFH¶
country.  The product of the population size in an age-gender group of a particular country and the 
risk of death from the reference distribution produces the number of unavoidable deaths in this 
country.  Finally, the difference between the actual number of deaths and the number of calculated 
unavoidable deaths gives the number of deaths which could have been avoided in this country if it 
had as many resources and used them as effectively as the reference country (Tang, Petrie et al. 
2009).  However, this approach is subject to a number of limitations imposed by the availability of the 
data and strong underlying assumptions.  
 
In summary, the way avoidable mortality is measured has undergone considerable changes over 
time, largely to reflect advances in medical knowledge and technology and to incorporate 
improvements in life expectancy, and across countries, mainly to adapt the list of amenable conditions 
to the characteristics of a specific country and/or to overcome data limitations. 
 
 
  
                                                          
2 See Table A1 in the Appendix with the list of conditions and their ICD-9 and ICD-10 codes considered avoidable from Nolte 
and McKee (2004) and Page, Tobias et al (2006) 
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Table 1: Differences in findings due to the use of different list as avoidable mortality 
Findings &KDUOWRQ¶VOLVW +ROODQG¶VOLVW 
Number of conditions 14 (Hypertensive disease, cancer 
of cervix uteri, pneumonia and 
bronchitis, tuberculosis, asthma, 
chronic rheumatic heart disease, 
acute respiratory disease, 
EDFWHULDOLQIHFWLRQV+RGJNLQ¶V
disease, abdominal hernias, acute 
and chronic cholecystitis, 
appendicitis, maternal deaths, 
iron deficiency anaemia,  
perinatal
3
) 
16 MCIs (tuberculosis, chronic 
rheumatic heart disease, 
abdominal hernias, cholelithiasis 
and  cholecystitis,  appendicitis, 
asthma, maternal deaths, cancer 
of cervix uteri, cervix and body 
uteri, hypertensive and 
cerebrovascular disease,  
respiratory disease, whooping 
cough, osteomyelitis, tetanus, 
measles, typhoid, ) and 3 HPIs 
(cirrhosis of liver, cancer of 
trachea, bronchus and lung, 
motor vehicle accidents) 
Criteria for the choice of the 
causes of death 
 Conditions which are mainly 
preventable are excluded (e.g. 
lung cancer). 
 Age limits were set for each 
cause to increase the proportion 
of mortality potentially avoidable. 
 Out of the remaining 
conditions only those that had 
more than 200 deaths in an age 
group in England and Wales in 
these age groups were included.  
 &KDUOWRQ¶VFDXVHVZHUH
used as a base, 3 health policy 
indicators were added. 
 Representatives from all the 
EC countries ranked the 
importance of diseases. 
 Selection of each cause was 
supported by the reference from 
medical literature identifying the 
corresponding effective 
intervention and existence of 
providers. 
Ratio of avoidable mortality to 
total mortality 
3% 22% 
Average mortality over 1981-1998 Higher for women than for men Higher for men than for women 
Group with the highest prevalence 
of avoidable mortality 
Men aged 15-24 Women aged 25-39 
Overtime trend Relatively small decline Large decline 
Degree of within district variation 
in the proportion of premature 
mortality considered avoidable 
Significant  Significant but smaller than for 
&KDUOWRQ¶VGHILQLWLRQ 
Geographical distribution Low SMRs in north of England 
and Scotland, high SMRs in 
South Wales and England with 
pockets of concentration of high 
SMRs in and close to London. 
Follows north-south pattern 
(similar to the pattern of overall 
premature mortality) with a 
concentration around Glasgow 
and other districts in Western 
Scotland. 
Within-district, between-ward 
geography 
Similar Similar 
Gender difference in the degree 
of variance and geography 
Substantial, with considerable 
more variance for men than for 
women. 
Little 
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3. Recent ePSLULFDOUHVHDUFKRQµDYRLGDEOHPRUWDOLW\¶ 
 
3.1 Later empirical studies 
 
Although there is no unanimous view in the literature on the ways of defining and measuring 
avoidable mortality, the concept itself is quite useful as it offers a relatively simple way to evaluate the 
performance of the healthcare sector. In this context, empirical studies of avoidable/ amenable 
mortality provide useful information on differences in this health outcome along various dimensions. 
 
Empirical studies on avoidable/amenable mortality have been thoroughly reviewed by Nolte and 
McKee (2004).  An overview of more than 70 studies allowed the authors to generalise findings on the 
topic up to the year 2004.  Most of these studies focus on high-income countries, with a few 
specifically addressing the situation in the former socialist countries.  The studies which focus on 
geographical variation in avoidable mortality rates, usually find little association between avoidable 
mortality and quantity (quality) of healthcare services, but significant association with the socio-
economic conditions in the region.  The studies focusing on socio-demographic variation tend to find 
that socially disadvantaged/ vulnerable groups are at a higher risk of death from avoidable conditions. 
Finally, the studies devoted to the analysis of time trends mostly show a consistent decline in 
avoidable mortality over time, which is more pronounced than the decline in all-cause mortality. 
 
This section revisits the review of empirical studies by Nolte and McKee (2004) and expands on it by 
analysing more recent empirical literature up until 2010. 
 
The literature search from 2004 onwards identified 39 empirical studies of avoidable mortality.  
Following Nolte and McKee (2004) the recent studies were analysed using the same structured 
protocol: (1) study region, (2) time period under investigation, (3) aim of study and definition of 
avoidable mortality, (4) causes of death and age group(s) under study, (5) analytical design and (6) 
main results.  This information is used to compile the annotated bibliography (similar to the one in 
Nolte and McKee (2004)) which can be found in the Appendix, Tables A2-A4.  Studies are grouped 
according to their study focus. Within each summary table, papers are sorted in alphabetical order 
according to the country under the investigation, and the year of publication. 
 
In contrast to the previous empirical literature, the studies from 2004 onwards are much more 
homogeneous in terms of the selection of causes of deaths and methodological approach.  11 out of 
WKHVWXGLHVDUHEDVHGRQ1ROWHDQG0F.HH¶V(2004) list of 33 conditions amenable to medical care 
and Ischemic Heart Disease (most often analysed separately).  Three further studies use the same 
list, but focus on a selection of causes.  One study is based on an earlier version of Nolte and 
0F.HHµV(Nolte, Scholz et al. 2002) list, which is 5 conditions shorter.  Six studies use one or another 
YDULDQWRI+ROODQG¶V OLVWV (1988; 1991; 1997), while six others are based on the work by Tobias and 
Jackson (2001) and Page, Tobias et al. (2006).  There are also studies which analysed either one or 
a selected number of causes of avoidable mortality (Schwarz and Pamuk 2008; Schwierz and Wübker 
2009). 
 
Perhaps reflecting the influence of the Nolte and McKee (2004) study, the recent literature shows 
much less variation in the terminology used. Most studies used the term avoidable mortality to apply 
to mortality from conditions amenable to both health (medical) services and health policies.  Usually 
these two sets of conditions have been analysed separately and have also been denoted as 
µWUHDWDEOH¶ DQG µSUHYHQWDEOH¶ RU µPHGLFDO FDUH LQGLFDWRUV¶ DQG µKHDOWK SROLF\ LQGLFDWRUV¶ UHVSHFWLYHO\
Among the first group, Ischemic Heart Disease has usually been highlighted as one of the biggest 
killers and studied separately as not all cases of deaths from IHD can be considered amenable to 
medical care.  The degree of avoidability of death from IHD is somewhere between 25% and 75% 
(Nolte and McKee 2004).  In most studies, 50% of the deaths from IHD have been considered as 
amenable to medical care, whilst two did not apply this percentage (James, Manuel et al. 2006; 
Korda, Butler et al. 2007). In addition, some authors added HIV/AIDS as a cause amenable to health 
policies and analysed it separately (Stirbu, Kunst et al. 2006; Macinko and Elo 2009).  A considerable 
number of studies focused only on mortality amenable to medical care and called them either 
µDPHQDEOH¶ PRUWDOLW\ RU µPHGLFDO FDUH LQGLFDWRUV¶ (Nolte, Scholz et al. 2004; Bautista, Alfonso et al. 
2005; Grant, Munoz-Arroyo et al. 2006; Stirbu, Kunst et al. 2006; Tobias and Yeh 2007; Weisz, 
Gusmano et al. 2008; Tobias and Yeh 2009). 
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With respect to the method used, 7 studies in our list were based on a cross-sectional analysis, 11 
undertook a time trend analysis and 21 studies explored both cross-sectional and time dimensions of 
avoidable mortality (only two of which exploited the panel nature of the data).  18 studies analysed 
variation in avoidable/ amenable mortality by socio-demographic characteristics, among which some 
represent cross-sectional analysis while others study also the variation in time trends.  Unlike the 
previous review, no study presented descriptive analysis at regional/country level at a point in time. 
Seven country/ regions studies covered considerable time periods.  Five studies compared trends in 
different regions of the same country or across countries. 
 
The list of reviewed studies mostly focused on high income countries (as before) with three evident 
FOXVWHUVRIµDYRLGDEOH¶PRUWDOLW\UHVHDUFK8.(Grant, Munoz-Arroyo et al. 2006; Gubb 2007; Wheller, 
Baker et al. 2007), Australia and New Zealand (Korda and Butler 2006; Page, Tobias et al. 2006; 
Korda, Butler et al. 2007; Tobias and Yeh 2007; Li, Gray et al. 2009; Tobias and Yeh 2009), and 
Spain (Bautista, Alfonso et al. 2005; Gispert, Gervas et al. 2007; Gispert, Serra et al. 2008; Melchor, 
Nolasco et al. 2008; Nolasco, Melchor et al. 2009).  6 studies either focused or included in the 
analysis countries of Central and Eastern Europe (Logminiene, Nolte et al. 2004; Newey, Nolte et al. 
2004; Nolte, Scholz et al. 2004; Treurniet, Boshuizen et al. 2004; Burcin 2009; Schwierz and Wübker 
2009). 
 
Regarding the time period, most studies covered the 1990s and the 2000s, but some authors have 
extended the analysis further in the past and included data from early 1980s (Nolte, Scholz et al. 
2004; Treurniet, Boshuizen et al. 2004; Grant, Munoz-Arroyo et al. 2006; Page, Tobias et al. 2006; 
Macinko and Elo 2009; Tobias and Yeh 2009) and a few even from 1970s and late 1960s (James, 
Manuel et al. 2006; Korda and Butler 2006; James, Wilkins et al. 2007).  As before, the major theme 
is documentation of the downward trends in avoidable mortality as measures of quality of healthcare 
systems and comparison of the relative performance of regions and/or countries in this regard.  
Compared to the previous literature, there is a sizeable growth in the analysis of socio-economic and 
demographic disparities in avoidable mortality (18 out of 39 studies reviewed here compared to 11 out 
of 70 reviewed in Nolte and McKee (2004)).  The rest of the section will compare the findings from the 
previous literature to the most recent ones in more detail. 
 
3.1.1 Geographical variation 
 
Nolte and McKee (2004) reported how avoidable mortality differs geographically, with these variations 
usually explained in terms of healthcare inputs and socio-economic factors.  The results show 
generally weak and inconsistent associations with healthcare inputs.  However, socio-economic 
factors (e.g. education, unemployment, socio-economic status, income level) were found to be 
strongly associated with avoidable mortality. 
 
The more recent literature on geographical variation in avoidable mortality mostly focuses on 
analysing and reporting time trends for various countries; provides ranking of countries with respect to 
avoidable mortality and/or change in avoidable mortality.  The overall trend is that the rates of 
avoidable mortality have been declining much faster in the last decade of the 20
th
 century and early 
years of the 21
st
 century.  Further, the rates of decline in mortality determined by Schwierz and 
Wubker (2009) confirm this finding in that they show that the increased use of intra-cardiac catheter 
facilities (an important diagnostic tool for IHD) is significantly related to decreases in avoidable 
mortality from IHD.  
 
Several studies found France to have the lowest avoidable mortality rates, while UK and USA are 
among those with the highest avoidable mortality rates, although they have experienced a 
considerable decline in this indicator over the recent years.  Countries which joined the EU in 2004 
have shown considerable improvements with respect to treatable mortality since 2004, and this 
despite the significant deterioration in health at the start of the transition period.  Furthermore, there is 
a difference observed in the time trends of mortality amenable to medical care and that amenable to 
health policies.  Although the first indicator has been declining over time in all countries studied, 
mortality amenable to health policies has been declining at a considerably slower pace and in some 
countries has in fact been on the rise (Newey, Nolte et al. 2004). 
 
A full summary of the studies that focus on geographical variations is presented in Table A2 in the 
Appendix. 
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3.1.2 Socio-demographic variation 
 
As avoidable mortality constitutes deaths that should not occur in the presence of timely healthcare, 
socio-demographic/economic inequalities in this indicator can be interpreted as stemming from the 
differential access to healthcare services or differences in the quality of care received by various 
groups.  These studies mostly concern countries with historical ethnic inequalities, but also those 
which have been experiencing a significant growth of migrant population.  
 
Earlier studies of variation in avoidable mortality by race in the United States have shown a consistent 
significant difference between whites and non-whites.  As Nolte and McKee (2004) summarised, in 
the 1980s the avoidable/ amenable mortality rates from selected causes were three to nine times 
higher for African-Americans than for white Americans (2.6 times higher for cervical cancer and 8.9 
times higher for tuberculosis).  The study by Macinko and Elo (2009), using the Nolte and McKee 
(2004) list of avoidable causes and covering the period from 1980 to 2005, confirmed this finding.  So, 
in 1980 the ratio of black to white mortality amenable to medical care was 2.9 for men and 2.2 for 
women.  This ratio remained stable up to the year 1998 showing a slight improvement for men only in 
1999 (2.6) and 2005 (2.5).  
 
Similarly the ethnicity gap was explored in New Zealand and Australia. Earlier literature found a 
decline in the ratio of the Maori to non-Maori amenable mortality ratio from 2.3-2.5 to 2 over the period 
1968-1987 (Malcolm and Salmond 1993) returning back to 2.5 in 1996-97 (Tobias and Jackson 
2001).  The findings from the Atlas of Avoidable Deaths for Australia and New Zealand (Page, Tobias 
et al. 2006) indicate no change in Maori/Europeans (others) amenable mortality ratio up to the year 
2001 and reports a worsening of the ratio for avoidable mortality (treatable and preventable) from 2.15 
in 1986 to 2.73 in 2001.  The same study considered the change in outcomes for Pacific compared to 
Europeans (others) over the same period.  The ratio of Pacific/ Europeans (others) for amenable 
mortality increased from 1.61 in 1986 to 2.27 in 2001, for avoidable mortality from 1.4 to 2.1.  Li et al. 
(2009) added to this literature by studying the Northern Territories and comparing the avoidable 
mortality among Aboriginal and Non-Aboriginal population there and with all Australian population.  It 
turned out that among non-Aboriginal NT population avoidable mortality was close to being the same 
as the overall Australian avoidable mortality (the ratio ranges from 1 to 1.2 over the period from 1985 
to 2004).  At the same time the ratio of NT Aboriginal population avoidable mortality to that of 
Australian was consistently increasing over the period from 2.8 to 4.3 for males and from 3.1 to 4.9 for 
females.  This increase was mostly due to the worsening of the differences in mortality amenable to 
health policies, while the difference in mortality amenable to medical care slightly improved over time.  
 
Stirbu et al. (2006) documented a slightly higher risk in total avoidable mortality for the migrant 
population in the Netherlands (relative risk of 1.3) with relative risks greater than 3 for all infectious 
diseases and greater than 1.7 for several chronic conditions including asthma, diabetes and 
cerebrovascular disorders.  Most of the ethnic difference was explained by demographic and socio-
economic characteristics of the migrant population relative to the native Dutch. 
 
The literature that provided evidence on inequalities in amenable/avoidable mortality by ethnicity and 
race was reinforced by the studies of socioeconomic variations in these measures, which support the 
earlier finding of a significant income gradient in amenable mortality.  Two studies used individual 
level data to compare the likelihood of deaths from avoidable causes depending on socio-economic 
factors.  Hjern, Vinnerljung et al. (2004) found that being a foster child or other welfare recipient 
increases the likelihood of deaths from suicide or from other avoidable cause even after controlling for 
the characteristics of the biological mothers.  Bautista et al. (2005) in a matched case-control study at 
a Spanish hospital concluded that the only significant factor in determining the likelihood of death from 
avoidable causes is education. Individuals with low or middle level of education are at a much greater 
risk than those with higher levels of education (adjusted odds ratios are 3.6 and 2.8 respectively). 
 
In the earlier literature differences in avoidable/ amenable mortality were also reported between blue 
and white collar workers, working and non-working population (Westerling, Gullberg et al. 1996). 
 
To summarize, the most recent literature as well as the earlier studies, despite differences in the 
study design, region or the time period considered, find that there is a much greater risk of death from 
avoidable/ amenable causes for those who are considered disadvantaged because of either ethnicity 
or socio-economic status. Furthermore, no evidence is found for the narrowing of this gap.  
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Table A3 in the Appendix provides information on all studies investigating socio-demographic/ 
economic variation in avoidable/ amenable mortality. 
 
3.1.3 Time trends 
 
All studies of avoidable mortality generally show a significant decline in mortality from causes 
amenable to medical care and that this decline is much stronger than the decline in mortality from 
µQRQDPHQDEOH¶FDXVHV :KHOOHU%DNHUHWDO (2007) for England and Wales estimated a 3.3-3.6% 
annual decline in amenable mortality for males and a 2.9-3.2% for females depending on the list of 
conditions used to measure amenable mortality over the period from 1993 to 2005.  This is similar to 
the estimated annual decline of 3.6% over the period between 1970/74 and 1985/87 for the whole 
population and is somewhat higher than the 2.7% decline found for the period between 1955/59 and 
1970/74 (Boys, Forster et al. 1991).  In Australia the average annual decline was 3.5% for males and 
3.9 % for females over the period from 1968 to 2001 (Korda and Butler 2006).  Similarly, in South 
Korea the annual decline of 3.7% for mortality from treatable conditions and of 2.4% for mortality from 
preventable conditions was observed over the period from 1983 to 2004. 
 
A summary of the literature on time trends in avoidable mortality can be found in Table A4 in the 
Appendix.  
 
3.2 UK studies 
 
Table 2 summarizes the findings from 7 studies of time trends in amenable mortality measures, 
however defined, for the United Kingdom.  It includes studies that either directly estimated avoidable 
mortality rates as a percentage of all-cause mortality or that included figures that allowed us to 
calculate these percentage rates. The studies are from 2004 onwards for the UK or for England and 
Wales only.  In order to compare with previous time periods, the results by Boys, Forster et al. (1991) 
and Nolte and McKee (2004) are also reported.  
 
Four of the studies focus on very similar conditions considered amenable.  These also analyse 
separately deaths from IHD (Newey, Nolte et al. 2004; Nolte and McKee 2004; Wheller, Baker et al. 
2007; Nolte and McKee 2008).  Three further studies provide comparable estimates with respect to 
mortality amenable to medical care from 1980 to 2003, whilst two other studies allow for the 
comparison of mortality amenable to both medical care and health policies (from 1990 to 2008).  In 
1980s, avoidable mortality from causes other than the IHD constituted about 20% of all-cause 
mortality for males and about 36% of that for females. In 2003, these numbers fell to 16% and 28% 
respectively.  Mortality from causes amenable to health policies remained stable or even increased 
slightly over this time period.  For example, Newey, Nolte et al. (2004) show that from 1990/91 to 
2002/03 this changed from 13.5% to 13.9% for males and from 9.7% to 11.5% for females.  If 
considered jointly, avoidable mortality (both medical care indicators and health policy indicators) over 
the period from 1990 to 2008 declined from about 30% for males and 41% for females to about 28% 
and 32% respectively.  Further, avoidable mortality from IHD in 1980 represented 34% of all-cause 
mortality for males and 20% for females.  However, this has changed dramatically over time with the 
latest estimates being 14.8% for males and 7.9% for females. 
 
Overall, mortality from conditions amenable to healthcare and health policy has declined from 1955 to 
2008.  In every period studied, the decline in non-avoidable mortality was much smaller than the 
decline in avoidable mortality.  The decline in mortality rate for IHD in 1970-87 was comparable to the 
decline in non-avoidable mortality.  However, in the periods that follow (starting from the late 1980s) 
the decline in the avoidable mortality rate for IHD has been considerably greater than that for other 
avoidable causes.  It is clear from these findings that avoidable mortality (as a percentage of all-cause 
mortality) over the last half of the 20
th
 century and first 8 years of the 21
st
 century has been declining 
by an average of 3% a year.  At the same time non-avoidable mortality (as a percentage of all-cause 
mortality) has been declining on average by less than 1% a year.  These estimates for the UK seem 
to suggest that the healthcare sector may have had a role in reducing all-cause mortality and 
avoidable mortality. The precise causal connection and the degree of this connection is, however, yet 
to be investigated and explained. 
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Table 2: Changes in amenable mortality over time in the United Kingdom: summary of results from selected sWXGLHVRIµaYRLGDEOH¶mortality 
 
 
Time 
period 
Country Causes amenable to medical care / health policy IHD All other 
causes 
All causes 
No. causes 
(age) 
% of all deaths Change/year 
(%) 
% of all deaths Change/year 
(%) 
Change/year 
(%) 
Change/year 
(%) 
Boys, Forster et al. 
1991 
1955-1987 ENG& 
WALES 
22 
(0-64)* 
1985-87:  12.2 1955-70: -2.7 
1970-87: -2.9 
1985-7^: 42.9 1955-70:  n.a 
1970-87: -0.9 
1955-70:  n.a 
1970-87:  -0.9 
1955-70:  -0.7 
1970-87:  -1.3 
Treurniet, 
Boshuizen, and 
Harteloh 2004 
1980-1998 UK 19 (MCI+HPI) 
(0-64) 
 
n.a 
1980-89:  -3.1 
1989-98:  -2.1 
 
n.a 
 
n.a 
1980-89:   -1.2 
1989-98:   -2.6 
 
n.a 
Newey, Nolte, et al. 
2004 
1990-2002 UK 33MCIs, 
3HPIs,IHD 
(0-74)* 
1990/91:  
16.0/13.5 (m), 30.9/9.7 (f) 
2002/03: 
16.3/13.9(m), 27.7/11.5 (f) 
m  -2.0  
f    -2.4 
  m    -3.8   
f      -3.9 
m     -0.8   
f       -0.5 
m     -2.1   
f       -1.8 
Nolte and McKee 
2004 
1980,1990, 
1998 
UK 34 (MCI+HPI), 
IHD 
(0-74)* 
1980: 19.6 (m) 35.9 (f) 
1990: 15.9 (m) 30.8 (f) 
1998: 17.4 (m) 29.9 (f) 
1980-90:               
m -3.5    f   -2.8 
1990-98:               
m   -1.3  f   -2.1  
1980: 33.7 (m) 20.1 (f) 
1990: 31.4 (m) 19.7 (f) 
1998: 25.6 (m) 15.1 (f) 
1980-90:        
m  -2.5  f   -1.7 
1990-98:        
m  -4.1  f   -4.2  
1980-90:        
m  -0.9  f   -0.4 
1990-98:        
m  -1.4  f   -0.6  
1980-90:        
m  -1.9  f   -1.5 
1990-98:        
m  -2.2  f   -1.8  
Nolte and McKee 
2008 
1997/98 
and 
2002/03 
UK 33 (MCI+HPI), 
IHD  
(0-74) 
1997/98: 17.4 (m), 29.9 (f)     
2002/03: 16.2 (m), 27.6 (f) 
m  -3.0     
f    -2.8 
1997-98: 12.8 (m), 7.6 (f)         
2002-03: 10.7 (m), 5.7 (f) 
 
m  -4.4    
f    -5.3 
m   -0.6     
f      0.0 
m    -2.0    
f      -1.7 
Wheller et al. 2007 
(ONS web-site)§ 
1993-2008 ENG & 
WALES 
35 (MCI+ HPI) 
(0-74) 
1993: 36.0 (m), 41.6 (f) 
2000: 33.4 (m), 38.3 (f) 
2008: 27.7 (m), 32.2 (f) 
m   -3.4  
f     -3.1 
1993: 23.1 (m), 15.2 (f) 
2000: 19.1 (m), 11.6 (f) 
2008: 14.8 (m), 7.9 (f) 
m    -3.9   
f      -4.1 
m     -1.1   
f       -0.6 
m     -2.6  
f       -2.2 
Gubb 2007 1999-2005 ENG & 
WALES 
12 
(0-74) 
   -5.9   
 
* - age varies for some causes (see the bibliographic table below for the information on studies dated 2004-2008 and Nolte and McKee (2004) for earlier studies), ^ - 25-64 age limit for IHD, § - 
figures for England separately are not reported here for the lack of difference with England and Wales. 
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 6RPH OLPLWDWLRQV RI WKH HPSLULFDO DSSOLFDWLRQ RI WKH FRQFHSW RI µDYRLGDEOH
PRUWDOLW\¶ 
 
5XWVWHLQ¶VVHPLQDO LGHD WRXVHKLV OLVWRIFRQGLWLRQV IRUZKLFKGHDWKFRXOGEH avoided by timely and 
effective healthcare as indicators of the poor quality and effectiveness of healthcare, has over the 
years received a number of criticisms.  In this section, we will briefly summarise some of these 
criticisms. 
 
One of the most striking criticisms raised is the lack of a significant association found between 
avoidable mortality rates and healthcare inputs.  The main argument posed is that healthcare inputs 
(e.g. number of doctors and nurses, expenditure, etc.) are not an ideal measure of healthcare as 
these merely reflect quantity and not the quality of healthcare.  
 
Second, counts of deaths from amenable conditions are taken from death certificates compiled by 
medical doctors.  Hence, some of the differences that we detect both at the country/regional level and 
over time may be due to dissimilarities in the death certification procedures and in diagnostic patterns 
(Nolte and McKee 2004).  These limitations do not, however, undermine the concept of avoidable 
mortality itself but rather the use of these statistics as a source of data. 
 
A further drawback of using death registries is that no mention is given to the incidence and severity 
of the diseases under investigation. In fact, no data on the incidence or severity of the disease seem 
to be reported in the studies on regional mortality.  This poses a significant challenge to the 
interpretation of time trends and cross-regional differences in avoidable mortality as attributable to 
differences in healthcare quality.  For example, an increase in the mortality rate due to 
tuberculosis/other disease in developed countries may be related to an increase in the incidence of 
the disease, for example due to immigration from countries with a high incidence of TB, and this 
certainly should not be attributed to a decline in the quality of healthcare.  Further, the severity of a 
GLVHDVHPD\EHGXHWR LQGLYLGXDOV¶KHDOWK-seeking behaviour, which may also vary by region and/or 
over time.  Although this kind of behaviour may be affected by active health promoting policies, it is to 
a great extent outside the scope and control of healthcare providers.  Despite these concerns, studies 
which do control for the incidence of a disease as measured from hospital discharge data (Carr, 
Szapiro et al. 1989; Treurniet, Looman et al. 1999) find a significant degree of variation in avoidable 
mortality, which is not explained by its incidence for the majority of conditions.  
 
Another problem is posed by the introduction of somewhat arbitrary age limiWV 5XWVWHLQ¶VHWDO OLVW
(1976) already contains some restrictions by age: e.g. only deaths occurring to people younger than 
50 years from acute respiratory infections, influenza, pneumonia, and bronchitis are considered 
avoidable.  Later studies imposed age limits on most conditions and these have been increasing over 
time.  Unfortunately, these impositions and extensions of age limits seem to be poorly justified.  Most 
studies do not provide any rationale for the age limits, while explanations of others could be 
questioned.  For example, Charlton et al. (1983) VHW WKHDJH OLPLWV IRUHDFKFDXVH ³WR LQFUHDVH WKH
SURSRUWLRQRIPRUWDOLW\SRWHQWLDOO\DYRLGDEOH´+ROODQG (1986) ± WR LPSURYH³YDOLGLW\RIPRUWDOLW\DVDQ
LQGLFDWRU RI KHDOWK VHUYLFH RXWFRPH´  1olte and McKee (2004) justify the setting of age limits for 
hypertension and stroke by referring to two large studies of systolic hypertension which summarized 
the existing evidence from clinical and epidemiological observational studies.  However, this is 
provided only as an example and age limits for other conditions are simply FKRVHQ WR ³UHIOHFW
LQFUHDVLQJH[SHFWDWLRQRIOLIH´DQGto acknowledge the problem with the reliability of death certification 
at older ages.  At the same time they confirm that the imposition of age limits should be an important 
issue in the debate on avoidable mortality that had not yet been properly addressed.  A later study by 
Page et al. (2006) provides the following general arguments for further extending the age limit: (i) 
increase in overall life expectancy (now about 80 years in developed countries), (ii) better health at 
ROGHU DJH SUREDEO\ UHODWLQJ WR IHZHU FRPRUELGLWLHV DQG LLL EHWWHU FRGLQJ ³ZKLFK DOORZHG D VLQJOH
FDXVHWREHFRGHGIRUPRVWGHDWKV´LQVSLWHRIPXOWLSOe comorbidities. 
 
7KHUHLVDOVRFRQFHUQZLWKUHVSHFWWRWKHGHJUHHRIµDYRLGDELOLW\¶RIGHDWKVIRUFHUWDLQGLVHDVHV7KHUH
is a clear understanding in the literature that not 100% of deaths in the list of avoidable conditions are 
truly avoidable.  However, the general consensus is that a substantial proportion of deaths should be 
avoided by medical intervention, prevention, or healthcare policies.  However, there are some 
conditions for which the proportion of avoidable deaths is far from substantial (if we think of 
substantial in the range of 80-90%).  For example, Poikolainen and Eskola (1988) developed a list of 
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µSDUWO\ DYRLGDEOH¶ FRQGLWLRQV ZLWKRXW SURYLGLQJ WKH UHDVRQV IRU VXFK D FODVVLILFDWLRQ  7RELDV DQG
Jackson (2001) XVHG H[SHUWV¶ RSLQLRQV WR DVVign weights for primary, secondary, and tertiary 
avoidable mortality, with primary being due to wider healthcare policies and prevention.  The problem 
ZLWK WKHVH SDUWLDO µDYRLGDELOLW\¶ ZHLJKWV LV WKDW RIWHQ WKH DXWKRUV GR QRW SURYLGH WKH JURXQGV IRU
assigning them, referring at best to expert opinion. One of the conditions that poses most difficulties in 
this respect is Ischemic Heart Disease (IHD), given that medical knowledge in this area has been 
growing rapidly in recent years.  Ideally one would like to have a systematic review of the medical 
literature, both experimental and epidemiological, on each of the avoidable mortality conditions so that 
an informed decision can be made on the appropriate degree of avoidability to assign to each 
condition. Nolte and McKee (2004) provide a review of the medical and epidemiological literature on 
the effectiveness of treatment for IHD and stroke, indicating for each the percentages of the 
effectiveness of various treatment.  However, their review is far from being systematic.  Based on the 
uncertainty surrounding the beneficial effects of healthcare on IHD, the authors choose to analyse it 
separately.  Some later studies (e.g. Page, Tobias et al. (2006)) based their choices of the degree of 
avoidability on Nolte and 0F.HH¶VFRQFOXVLRQVFODLPLQJWKDWRIPRUWDOLW\GXHWR,+'VKRXOGEH
considered avoidable. 
 
Finally, the list of avoidable conditions has been arbitrarily changed to adapt to particular contexts and 
RYHU WLPH  +RZHYHU LW VHHPV WKDW 1ROWH DQG 0F.HH¶V review of 2004 and their proposed list has 
offered a consolidated platform for subsequent studies. 
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5. Conclusions and future work 
 
This review of the literature has described the concept of avoidable mortality from its first inception to 
PRUHUHFHQWGD\VDQGVXPPDULVHGLWVHPSLULFDODSSOLFDWLRQVIROORZLQJ1ROWHDQG0F.HH¶VH[WHQVLYH
review of 2004, to which this review poses as an important update.  
 
We found that the empirical applications of the notion of avoidable mortality have been widely used to 
establish the extent to which people are dying from amenable conditions within and/or across 
countries and over time, and whether socio-economic status and ethnicity are related to mortality from 
amenable conditions.  Most studies have used data drawn from national death registries, with only 
two which to our knowledge have attempted to link the concept of avoidable mortality to routinely 
collected administrative data of healthcare provision, such as hospitals. A number of criticisms have 
been raised, with probably the most remarkable being the lack of association found between 
avoidable mortality and healthcare inputs. None have actually attempted to use the concept of 
avoidable mortality within the original aim envisaged by Rutstein, i.e. as a quality indicator of 
healthcare provision.  
 
Future work in this area should focus on investigating the link between the provision of healthcare and 
the concept of avoidable mortality, with a particular emphasis on using routinely collected 
administrative data, such as hospital discharge data. These usually contain information on important 
medical (diagnosis and treatments) and demographic characteristics of the patients, as well as 
information of healthcare provision and resource use, and hospital characteristics.  This type of 
analysis would allow a better understanding of the links between avoidable deaths (both within 
hospital and after a certain time from discharge) and the provision of healthcare. But perhaps most 
importantly it would allow us to understand whether the list of conditions of avoidable mortality is a 
good indicator of the quality of healthcare provision. 
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Appendix 
 
Table A1: Causes of death considered amenable to healthcare and prevention  
 Nolte and McKee (2004) Page et al. (2006) 
Causes amenable to healthcare 
(avoidable, treatable) 
Age 
Limits 
ICD-9 
codes 
ICD-10 
codes 
Age 
limits 
ICD-9 
codes 
ICD-10 
codes 
Infectious diseases       
Intestinal infections  
(other than typhoid, diphtheria) 
0-14 001-009 A00-A09    
Other infections (diphtheria, tetanus,               
poliomyelitis) 
0-74 032, 037, 
045 
A36, 
A35, A80 
   
Whooping cough 0-14 033 A37    
Septicaemia  0-74 038 A40-A41    
Measles 1-14 055 B05    
Selected invasive bacterial and protozoal    0-74 034-036, 
038, 084, 
320, 481, 
482, 485, 
681, 682 
A38-A41, 
A46, 
A48.1, 
B50-B54, 
G00, G03, 
J02.0, 
J13-J15, 
J18, L03 
Hepatitis    0-74 070 B15-B19 
HIV/AIDS    0-74 070 B20-B24 
Tuberculosis  0-74 010-018, 
137 
A15-A19, 
B90 
0-74 010-018, 
137 
A15-A19, 
B90 
Influenza 0-74 487 J10-J11 0-74 487 J10 
Pneumonia (only viral in PT)  0-74 480-486 J12-J18 0-74 480 J12, 
J17.1, J21 
Neoplasms       
Colon  
and rectum 
0-74Á 153-154 C18-C21 0-74 153-154 C18-C21 
Melanoma of skin    0-74 172 C43 
Skin (nonmelanotic) 0-74Á 173 C44 0-74 173 C44 
Breast 0-74 174 C50 0-74 174 C50 
Cervix uteri 0-74 180 C53 0-74 180 C53 
Vervix uteri and body of the uterus 0-44 179, 182 C54, C55 0-74 179, 182 C54, C55 
Testis   0-74Á 186 C62    
+RGJNLQ¶VGLVHDVH 0-74Á 201 C81 0-74 201 C81 
Leukaemia (only lymphoid in PT) 0-44 204-208 C91-C95 0-74 204.0, 
204.1 
C91.0, 
C91.1 
Thyroid    0-74 193 C73 
Lip, oral cavity and pharynx    0-74 140-149 C00-C14 
Oesophagus    0-74 150 C15 
Stomach    0-74 151 C16 
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 Nolte and McKee (2004) Page et al. (2006) 
Causes amenable to healthcare 
(avoidable, treatable) 
Age 
Limits 
ICD-9 
codes 
ICD-10 
codes 
Age 
limits 
ICD-9 
codes 
ICD-10 
codes 
Liver    0-74 155 C22 
Lung    0-74 162 C33, C34 
Bladder    0-74 188 C67 
Benign    0-74 210-229 D10-D26 
Nutritional, endocrine and metabolic 
conditions 
      
Diseases of the thyroid   0-74 240-246 E00-E07 0-74 240-246 E00-E07 
Diabetes mellitus   0-49 250 E10-E14 0-
74(§) 
250 E10-E14 
Neurological disorders       
Epilepsy 0-74 345 G40-G41 0-74 345 G40-G41 
Circulatory diseases       
Rheumatic heart disease  (Only Chronic in 
NM) 
0-44Á 393-398 I05-I09 0-74 390-398 I01-I09 
Hypertensive disease   0-74 401-405 I10-I13, 
I15 
0-74 402 I11 
Ischaemic heart disease  0-74($) 410-414 I20-I25 0-
74(§) 
410-414 I20-I25 
Cerebrovascular disease   0-74 430-438 I60-I69 0-
74(§) 
430-438 I60-I69 
Aortic aneurysm    0-74 441 I71 
All respiratory diseases (excluding 
pneumonia /influenza)  
1-14 460-479, 
488-519 
J00-J09, 
J20-J99 
   
Digestive disorders       
Peptic ulcer  0-74 531-533 K25-K27 0-74 531-534 K25-K28 
Appendicitis  0-74 540-543 K35-K38 0-74 540-543 K35-K38 
Abdominal hernia  0-74 550-553 K40-K46 0-74 550-553 K40-K46 
Cholelithiasis (& cholecystitis)  0-74 574-
575.1 
K80-K81 0-74 574-
575.1 
K80-K83, 
K85, K86, 
K91.5 
Chronic liver diseases (excluding alcohol 
related) 
   0-74 571.4-
571.9 
K73, K74 
Genitourinary disorders       
Nephritis and nephrosis   0-74 580-589 N00-N07, 
N17-N19, 
N25-N27 
0-74 403, 580-
589, 591 
I12, I13, 
N00-N09, 
N17-N19 
Obstructive uropathy    0-74 592, 
593.7, 
594, 598, 
599.6 
N13, N20, 
N21, N35, 
N99.1 
Benign prostatic hyperplasia   0-74 600 N40    
Maternal and infant causes       
Maternal deaths  all ages 630-676 O00-O99    
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 Nolte and McKee (2004) Page et al. (2006) 
Causes amenable to healthcare 
(avoidable, treatable) 
Age 
Limits 
ICD-9 
codes 
ICD-10 
codes 
Age 
limits 
ICD-9 
codes 
ICD-10 
codes 
Birth defects    0-74 237.70, 
740-760 
H31.1, 
P00, P04, 
Q00-Q99 
Congenital cardiovascular anomalies  0-74 745-
747 
Q20-Q28    
Perinatal deaths all causes excluding 
stillbirths   
all ages 760-
779 
P00-P96, 
A33, A34 
0-74 764-779 P03, P05-
P95 
Respiratory diseases       
DVT with pulmonary embolism    0-74 415.1, 
451.1 
I26, I80.2 
COPD    45-74 490-492, 
496 
J40-J44 
Asthma    0-44 493 J45, J46 
Misadventures to patients during surgical 
and medical care  
DOODJHVÁ E870-
E876, 
E878-
E879 
Y60-Y69, 
Y83-Y84 
   
Drug use disorders       
Alcohol related disease    0-74 291, 303, 
305.0, 
425.5, 
535.3, 
571.0-
571.3 
F10, 
I42.6, 
K29.2, 
K70 
Illicit drug use disorders    0-74 292, 304, 
305.2-
305.9 
F11-F16, 
F18, F19 
Unintentional injuries       
Road traffic injuries    0-74 E810-
E819 
V01-V04, 
V06, V09-
V80, V87, 
V89, V99 
Falls    0-74 E880-
E886, 
E888 
W00-W19 
Fires and burns    0-74 E890-
E899 
X00-X09 
Accidental poisoning    0-74 E850-
E869 
X40-X49 
Drownings    0-74 E910 W65-W74 
Intentional injuries       
Suicide and self-inflicted injuries    0-74 E950-
E959, 
E980-
E989 
X60-X84, 
Y87.0, 
Y10-Y34 
Violence    0-74 E960-
E969 
X85-Y09, 
Y87.1 
ÁFRQGLWLRQQRWLQFOXGHGDVµDPHQDEOHFRQGLWLRQ¶LQ'HQPDUN)LQODQGDQG6ZHGHQ1ROWHDQG0F.HH 
(§) condition considered 50% amenable in Page et al. ($) Analysed separately in Nolte and McKee (2004)
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Table A2: Empirical studies of avoidable mortality ± analyses of geographical variation (cross-sectional and longitudinal) (2004 onwards) 
Author(s) Country/ 
region 
Time 
period 
Topic/aim of study Number of causes Design/method Results 
Nolte & 
McKee (2008) 
USA, 14 
western 
European 
countries, 
Canada, 
Australia, 
New Zealand 
and Japan 
1997-98 
and 2002-
03 
Rank countries by 
amenable mortality and 
estimate the overtime 
change focusing on the 
USA. 
µ$YRLGDEOHPRUWDOLW\¶
conditions amenable to 
healthcare with only 
half of the mortality 
from IHD considered 
amenable (treated 
separately). 
Basis: Nolte and McKee (2004) 
- 33 conditions plus IHD treated 
separately 
- Age limit 0-74 (diabetes 
mellitus under 50, intestinal 
infection, whooping cough, 
measles, childhood respiratory 
disease under 15, leukemia under 
44) 
Cross-sectional and time 
trend 
Age standardized death 
rates by sex at the country 
level, ranking of countries. 
By 2002-03 amenable mortality had fallen in all 
countries with the decline averaged at 17 
percent for males and 14 percent for females 
over the period from 1997-98. The decline in 
amenable mortality constituted more than 10 
percent for all countries except the US (4 % for 
males and 5% for females), Sweden (8% for 
females), and Denmark (9% for females). 
Nolte, Scholz, 
& McKee 
(2004) 
Lithuania, 
Hungary, 
Romania, 
West 
Germany (for 
comparison) 
1980-1997 Examine the 
contribution of 
healthcare into life 
expectancy in Central 
and Eastern Europe 
and compare the levels 
and trends to West 
Germany. 
 
µ$YRLGDEOH¶PRUWDOLW\
conditions amenable to 
secondary prevention 
or medical treatment. 
 
Basis: Nolte et al. (2002) 
- 28 conditions with IHD treated 
separately 
- Age limit 0-74 (diabetes under 
50) 
Cross-sectional and time 
trend 
Decomposition of 
differences in life 
expectancy due to deaths 
from avoidable conditions 
following Andreev (1982), 
Arriaga (1984) and Pressat 
(1985). 
In the 1980s, falling infant mortality from 
amenable conditions made a substantial 
contribution to improvements in temporary life 
expectancy in all countries. At older ages, falling 
amenable mortality contributed about 40% 
among those aged over 40 in Germany and, to a 
lesser extent, in Hungary, while causing a loss of 
life expectancy in Romania. In the 1990s, 
improvements in infant mortality continued to 
make substantial contributions to life expectancy 
in Lithuania and Hungary but had little impact in 
either Germany or Romania. Among adults, 
improvements in amenable mortality continued 
to benefit Hungarians and west Germans. In 
Lithuania, up to two-thirds of the gain in 
temporary life expectancy were attributable to 
falling mortality from ischaemic heart disease, 
whereas medical care otherwise seems to have 
had a negative impact. Romanian men and 
women experienced increases in amenable 
mortality that contributed up to a half of the 
overall loss of life expectancy. 
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Author(s) Country/ 
region 
Time 
period 
Topic/aim of study Number of causes Design/method Results 
Treurniet, 
Boshuizen, & 
Harteloh 
(2004) 
15 EU 
countries, the 
Czech 
Republic and 
Hungary 
1980-1997 Analyse international 
variations of trends in 
µDYRLGDEOHPRUWDOLW\¶ 
µ$YRLGDEOH¶PRUWDOLW\
causes amenable to 
both medical care 
interventions and 
national health policies. 
Basis: HROODQG¶VOLVW 
- 19 causes 
- Age limit 0-64 
Cross-sectional and time 
trend 
Age and sex directly 
standardized mortality rates 
(using European standard 
population) are studied 
employing a multilevel 
(random slope) model to 
estimate both a general 
Europe-wide trend and 
individual differences in 
trends among countries in 
AM. 
Avoidable mortality declined (1980±1997) in all 
the countries except Hungary. The difference 
between the trends in avoidable and non-
avoidable mortality was small (-2.4% compared 
to -1.5% per year. The largest trend variations 
between countries are attributable to causes 
mainly or partly amenable to prevention. For five 
of the 19 causes of death the international 
variations decreased over time. Various 
countries show trends that deviate significantly 
from the mean trend. 
Newey, Nolte, 
et al. (2004) 
25 EU 
member 
states, 
Bulgaria and 
Romania 
1990-2002 Examine the trends in 
treatable and 
preventable mortality in 
25 EU member states 
and 2 candidate 
countries between 
1990 and 2002. 
µ$YRLGDEOH¶PRUWDOLW\
treatable mortality, 
preventable mortality 
and IHD. 
Basis: Nolte and McKee (2004) 
- 33 treatable conditions, 3 
preventable and IHD 
- Age limit 0-74 (intestinal 
infections, whooping cough 0-14, 
measles, respiratory disease 
(excl. pneumonia and influenza) 1-
14, uterine cancer, leukemia 0-44, 
diabetes 0-49, maternal, perinatal 
deaths, misadventures to patients 
during surgical and medical care ± 
All) 
Cross-sectional and time 
trend 
Age standardized avoidable 
mortality rates by gender 
are compared between 
1990/91 and 2000/01/02 for 
25 EU member states, 
Bulgaria and Romania. 
Time trends for 7 countries 
(Hungary, Poland, Slovenia, 
Romania, Sweden and 
Portugal) are examined 
over the period 1990-2002. 
This analysis demonstrated a clear east-west 
divide in avoidable mortality in the early 1990s 
for both men and women. The findings suggest 
that both Romania and Bulgaria, scheduled to 
join the European Union in 2007, have a 
considerable way to go to achieve the health 
outcomes seen in their neighbouring EU 
countries (e.g. avoidable mortality in Romania 
and Hungary compared to Sweden in 1990/91 
was 4 times higher for men and 3 times higher 
for women, while all-cause mortality was only 
about double the rates). In contrast, most 
countries that have joined the European Union in 
2004 have made considerable progress in 
modernizing their health systems as reflected by 
the improvements in health outcomes, i.e. 
treatable mortality. 
  
20  Research Paper 63 
Author(s) Country/ 
region 
Time 
period 
Topic/aim of study Number of causes Design/method Results 
Weisz, 
Gusmano  et 
al. (2008) 
France, 
England and 
Wales and 
USA (Paris, 
Inner London 
and 
Manhattan) 
1988-1990 
and 1998-
2000 
Compare the three rich 
countries of the OECD 
in avoidable mortality 
and their largest cities. 
µ$YRLGDEOH¶mortality: 
premature deaths 
amenable to medical 
interventions. 
 
Basis: Nolte and McKee (2004) 
- 22 conditions (without IHD and 
with 50% of IHD deaths) 
- Age limit 1-75 years, childhood 
infections are excluded 
Cross-sectional and time 
trend 
Age and gender 
standardized mortality 
rates. Regression 
controlling for the income 
levels for the period 1998-
2000. 
France has the lowest mortality rates in both 
periods (1.38 and 1.19 per 1000 population 
respectively). The US exhibits higher overall 
mortality rates, but similar AM rates compared to 
England and Wales (when excluding the IHD 
deaths). Rates of AM are lowest in Paris and 
highest in London. Avoidable mortality rates are 
higher in poor neighbourhoods of all three cities; 
only in Manhattan is there a correlation between 
the percentage of deaths that are avoidable and 
an income related variable. 
Page, Tobias, 
et al. (2006) 
Australia and 
New Zealand 
1981-2001 Study the time trend of 
avoidable and 
amenable mortality in 
Australian and New 
Zealand regions and 
overall. 
µ$YRLGDEOH¶PRUWDOLW\
amenable causes 
(causes whose case 
fatality could be 
substantially reduced 
by currently available 
healthcare 
technologies; 
preventable causes 
(causes whose case 
fatality could be 
reduced by preventing 
the condition from 
occurring in the first 
place). 
Basis: Tobias and Jackson (2001) 
updated and revised 
- 27 amenable conditions 
(diabetes, IHD and 
cerebrovascular disease ± 50%) 
and 21 preventable conditions 
- Age limit 0-74 (asthma 0-44, 
chronic obstructive pulmonary 
disease 45-74) 
 
Cross-sectional and time 
trend  
Age standardized mortality 
rates by cause are 
analysed for both males 
and females. The 
associations between 
avoidable mortality and 
socio-economic status, 
ethnicity in different regions 
are described. 
Almost three quarters of all deaths at ages 0 to 
74 years in Australia and New Zealand for the 
period 1997 to 2001 were considered to be 
avoidable: 71.5% in Australia and 74.4% in New 
Zealand. In Australia, 40.2% of these avoidable 
deaths are considered to be amenable to 
healthcare. In New Zealand, the proportion is 
higher, at 43.2%. Total mortality at 0 to 74 years 
accounted for 41.5% of deaths at all ages in 
Australia, and 43.7% in New Zealand. There was 
also a clear socioeconomic gradient in rates for 
all causes of avoidable mortality and for most 
conditions examined. The Indigenous/Maori rate 
of deaths from avoidable causes was much 
higher than the rate for the European/non-
Indigenous population. 
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Author(s) Country/ 
region 
Time 
period 
Topic/aim of study Number of causes Design/method Results 
James, 
Manuel, et al. 
(2006) 
Canada 1975-1999 Examine mortality 
trends from avoidable 
causes in Canada. 
 
µ$YRLGDEOH¶PRUWDOLW\
conditions amenable to 
medical care or public 
health. 
Basis: Holland (1997) 
- 13 conditions amenable to 
medical treatment plus IHD 
analysed separately, and 3 health 
policy indicators 
- Age range 5-64 (IHD, 
hypertension, cerebrovascular 
disease, and lung cancer 35-64, 
breast cancer 25-64, cervical and 
XWHULQHFDQFHUDQG+RGJNLQ¶V
disease 15-64, ulcers 25-64, 
maternal mortality 0-64) 
Cross-sectional and time 
trend 
 
National and regional (5 
regions) age-standardized 
mortality rates using the 
direct method with Canada 
1991 as the reference 
population. 
From 1975-1979 to 1995-1999, the decrease in 
avoidable mortality (46.9%) was more 
pronounced compared to mortality from other 
causes (24.9%). There were persistent regional 
avoidable mortality differences with consistently 
lower avoidable mortality in Ontario and British 
Columbia compared to the Atlantic, Quebec and 
Prairies regions, with no difference in mortality 
from other causes. Injuries, IHD and lung cancer 
strongly influenced the overall avoidable 
mortality trends. 
Schwierz & 
Wubker 
(2009) 
East and 
West 
Germany 
1996-2004 Identify selected 
factors influencing the 
decrease in the 
number of avoidable 
deaths from IHD in 
West and East 
Germany. 
- IHD 
- Age limit 1-64 
Panel 
Age standardize mortality 
rate by the expected 
mortality for age groups, 
fixed effect with the panel 
data. 
Increasing number of intracardiac catheter 
facilities (an important diagnostic tool for IHD) 
significantly account for decreases in avoidable 
mortality from IHD. 
Sundmacher,
L. 
(forthcoming 
in 2011) 
Germany 2000-2004 Identify areas in 
Germany burdened by 
exceptionally high rates 
of amenable cancer 
mortality and 
investigate the 
marginal contribution of 
healthcare on 
amenable cancer using 
counties as the unit of 
analysis. 
µ$PHQDEOH¶WRPHGLFDO
care types of cancer. 
Basis: Nolte and McKee (2003), 
Ward et al. (2006) 
- 10 conditions (only  selected 
malignant neoplasm types) 
- Age limit 0-75 
Panel  
Age standardized death 
rates as dependant 
variables in the Poisson 
regression model with fixed 
effects and robust standard 
errors. 
Amenable cancer mortality rates differ 
significantly among small areas of Germany 
showing a clear north-south gradient in men and 
less in women (higher rates in the north). The 
regression results suggest that the quantity of 
healthcare, measured by the number of 
physicians and the number of beds in all 
hospitals, is not significantly associated with 
amenable cancer mortality. However, the 
differences in socio-economic and environmental 
factors do explain differences in amenable 
cancer mortality rates. 
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Author(s) Country/ 
region 
Time 
period 
Topic/aim of study Number of causes Design/method Results 
Bares, 
Gispert, et al. 
(2005) (in 
Spanish)  
Spain 
(Catalonia) 
1986-2001 Analyse time trends 
and geographical 
variation in avoidable 
mortality by health 
areas in Catalonia. 
µ$YRLGDEOH¶FDXVHV
those amenable to 
medical care and those 
responsive to health 
policy (preventable). 
 
 
Basis: Department of Health of 
Catalonia 
- 18 conditions 
- Age limit 5-64 (uterine cancer 
15-64, cardio rheumatic disease 
5-44, respiratory disease 1-14, 
asthma 5-44, hypertensive and 
cerebrovascular diseases 35-64, 
complications related to 
pregnancy and delivery, motor 
accidents ± all ages, cholera and 
tetanus 0-64, whooping cough 0-
14, osteomyelitis 1-64, cirrhosis 
15-74, ADS 20-49) 
Cross-sectional and time 
trend 
Age standardized mortality 
rates, Poisson regression to 
estimate time trends. 
The mean annual change for avoidable causes 
was -2.43% (95% CI, -2.60 to -2.26), higher than 
the -1.57% (95% CI, -1.61 to -1.52) change for 
general mortality. The rates were higher for 
preventable causes than for treatable causes, 
although mortality decreased in both groups. The 
health area of Segre was notable for its 
significantly higher mortality from both treatable 
and preventable causes in both periods. Four 
health areas showed a significant increase in 
mortality from preventable causes but none 
showed an increase in mortality from treatable 
causes. 
Duarte, 
Benach, et al. 
(2009) (in 
Spanish) 
Spain 1990-2001 Describe the 
geographical 
distribution of 
avoidable and non-
avoidable mortality in 
small areas in Spain by 
sex. 
µ$YRLGDEOH¶FDXVHV
those amenable to 
medical care (including 
IHD) and those 
responsive to health 
policy (preventable). 
Basis: Gispert et al. (2006) 
- 27 conditions 
- Age limit 0-74 (uterine cancer 
15-74, asthma 5-49, maternal 
mortality and adverse events 
during medical treatment or 
surgery ± all ages, IHD 35-74, 
leukaemia 0-14, diabetes 0-49)  
Cross-sectional and time 
trend 
Empirical Bayesian model-
based estimates of age-
adjusted relative risk were 
displayed in small-area 
maps for each group of 
causes of death by sex. 
There is a heterogeneous geographical 
distribution of avoidable mortality for both sexes. 
Areas with greater mortality are located in the 
south and northwest of Spain. Especially for 
hypertension, cerebrovascular disease and 
ischaemic heart disease in men there is a clear 
aggregation of deaths in these areas. 
Geographical distribution of non avoidable 
mortality in both sexes is similar to that described 
for these three causes.  
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Author(s) Country/ 
region 
Time 
period 
Topic/aim of study Number of causes Design/method Results 
Melchor, 
Nolasco, et al. 
(2008) (in 
Spanish) 
Spain 
(Valencia) 
1990-2004 Analyse time trends 
and the geographical 
distribution of 
avoidable mortality in 
the autonomous 
community of Valencia 
and its health 
departments by sex in 
the periods 1990-1994, 
1995-1999, and 2000-
2004. 
 
µ$YRLGDEOH¶PRUWDOLW\
conditions amenable to 
medical care and 
preventable. 
Basis: Holland (1991) 
- 17 treatable conditions and 4 
preventable conditions 
- Age limit 5-64 (uterine cancer 
15-64, cardio rheumatic disease 
and asthma 5-44, respiratory 
diseases 1-14, hypertension and 
cerebrovascular disease 35-64, 
maternal deaths, measles ± All, 
cholera and tetanus 0-64, 
whooping cough 0-14, 
osteomyelitis 1-64, cirrhosis 15-
74, accidents ± All, AIDS 20-24) 
Cross-sectional and time 
trend 
Age standardized mortality 
rates by sex are analysed 
over time and across the 
Valencia region. 
The total number of avoidable deaths was 
38,061 (7.1% of overall deaths). Men accounted 
for 76.2% and women for 23.8%. By groups, 
82.4% were preventable and 17.6% were 
treatable. Preventable deaths represented 
86.5% of deaths in men and 69.4% of those in 
women. Avoidable mortality in Valencia 
significantly decreased in both sexes, this 
decrease being more marked in the group of 
treatable deaths and in men. Mortality from lung 
cancer in women significantly increased. 
Between 2000 and 2004, none of the health 
departments showed a significant excess of 
treatable mortality. 
 
Gubb (2007) UK (England 
and Wales) 
1999-2005 Analyse time trends in 
WKHµELJJHVW¶NLOOHUVLQ
the UK (cancer and 
circulatory diseases) 
and compare the 
country position among 
other European 
countries. 
 
µ$YRLGDEOHPRUWDOLW\¶
mortality from 
conditions which are 
either amenable to 
treatment and medical 
care and/or amenable 
to secondary 
prevention through 
early detection. 
Basis: Nolte and McKee (2004): 
- 12 conditions (circulatory 
disease and cancer) analysed 
separately 
- Age limit 0-µPDOLJQDQW
neoplasm of cervix uteri and body 
RIWKHXWHUXV¶DQGµOHXNDHPLD¶
where an age-limit of 44) 
Cross-sectional and time 
trend 
Age standardized mortality 
rates. 
The major finding is that the rate of avoidable 
PRUWDOLW\IURPWKHWZRµPDMRUNLOOHUV¶FDQFHUDQG
circulatory diseases) has fallen over time at an 
increasing rate with the only exception for cancer 
between 1999 and 2005. The decrease in 
avoidable mortality for England and Wales was 
higher than the average for 11 European 
countries at similar level of development, but 
Austria that started at a similar position has 
performed much better. However, despite 
greater improvements AM still remains very high 
in England and Wales compared to other 
European countries. 
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Table A3: Empirical studies of avoidable mortality ± analyses of variation by socio-demographic factors (2004 onwards) 
Author(s) Country/ 
region 
Time period Topic/aim of study Number of causes Design/method Results 
Hayen, Lincoln, 
et al. (2004) 
Australia 
(New South 
Wales) 
1980-2000 Study the changes in 
inequalities by socio-
economic groups in 
potentially avoidable mortality 
over time. 
µ3ULPDU\DYRLGDEOHPRUWDOLW\¶
deaths from conditions which 
are preventable through 
change in individual 
behaviour or through health 
policies. 
Basis: Tobias and Jackson 
(2001) 
- 3 (lung cancer, road 
traffic injury, IHD) 
- Age limit 0-74 
Cross-sectional and time 
trend 
Age standardized mortality 
rates for local government 
areas, Poisson regression 
to assess changes in 
deaths rates by SES group 
after adjusting for age. 
Rates of Primary Avoidable Mortality have 
decreased steeply for the three SES groups 
(20% lowest, 60% middle, and 20% highest), 
with the rates decreasing by 51% in males and 
44% in females between 1980 and 2000. The 
relative gap between the highest and the lowest 
SES group and between the highest and the 
middle SES group increased for both males and 
females. The results are similar for all three 
conditions analysed separately. 
Korda, Butler et 
al. (2007) 
Australia 1986, 1991, 
1997, 2002 
Investigate the distribution of 
the benefits of healthcare 
across the SES distribution 
through the comparison of 
declines in avoidable and 
non-avoidable mortality. 
µ$YRLGDEOH¶PRUWDOLW\FDXVHV
amenable to medical care, 
causes mainly responsive to 
health policy, and IHD. 
 
Basis: Nolte and McKee 
(2004)  
- 34 conditions (Medical 
Care Indicators) plus IHD 
treated separately, plus 3 
Health Policy Indicators 
- Age limit 0-74 
Cross-sectional and time 
trend 
Pooled cross-section time 
trend analysis using the 
aggregated area data with 
two models: negative 
binomial and quasi-Poisson 
with SES, year and their 
interaction separately for 
avoidable and non-
avoidable mortality. The 
first model is used to 
identify differences in time 
trend for the Relative Index 
Inequality (= the ratio of the 
rate of mortality that is 
predicted for the lower end 
of the socioeconomic 
continuum to the rate of 
mortality for the higher 
end). The second ± for the 
Slope Index of Inequality 
(=absolute difference in 
standardized mortality 
ratios predicted for the 
lower and higher ends of 
socioeconomic continuum). 
The annual percentage decline in avoidable 
mortality at the higher end of the socioeconomic 
continuum was larger than that at the lower end, 
with relative inequality increasing between 1986 
and 2002, greater than that in non-avoidable 
mortality. In absolute terms, avoidable deaths fell 
annually by 7.4 and 8.4 deaths per 100 000 at 
the higher and lower end of the spectrum, 
respectively, with absolute inequality decreasing 
between 1986 (SII = 97.8) and 2002 (SII = 81.5).  
 
Avoidable mortality: what it means and how it is measured  25 
 
 
Author(s) Country/ 
region 
Time period Topic/aim of study Number of causes Design/method Results 
Piers, Carson, 
et al. (2007) 
Australia 
(Victoria) 
1979-2000 Describe trends in avoidable 
mortality in Victoria by sex, 
degree of socio-economic 
disadvantage and 
remoteness among local 
government areas (LGAs).  
Basis: Tobias and Jackson 
(2001) 
- 56 conditions (partitioned 
into primary, secondary, 
and tertiary prevention) 
- Age limit 0-74 
Cross-sectional and time-
trend 
Age standardized mortality 
rates by sex, tests of the 
differences in time trends 
using OLS regression 
methods for the logarithms 
of age standardized 
mortality rates (in log form). 
Total avoidable mortality rates declined 
significantly in both males and females between 
1979 and 2001, but were significantly higher in 
males compared with females and in rural 
compared with metropolitan LGAs. Total 
avoidable mortality rates in the least 
disadvantaged quintile were significantly lower 
than those in the most disadvantaged quintile 
over the entire five-year period in males and in 
three years in females. Total avoidable mortality 
rates were highest in remote LGAs and lowest in 
highly accessible LGAs.  
Li, Gray et al. 
(2009) 
Australia 
(Northern 
Territories) 
1985-2004 Analyse the rates of 
avoidable and non-avoidable 
mortality in Aboriginals and 
non-Aboriginal residents 
compared to the all-Australian 
magnitudes. 
µ$YRLGDEOH¶FRQGLWLRQVDUH
divided into conditions 
amenable to medical care, 
conditions responsive to 
population-based health 
policies, and IHD.  
Basis: Korda and Butler 
2006 (NM 2004) 
- 34 conditions (Medical 
Care Indicators) plus IHD 
treated separately, plus 3 
Health Policy Indicators 
- Age limit 0-74 
Time trend 
Age standardized mortality 
rates by sex and 
Aboriginality, NT and 
Australia (Poisson 
regression) 
Over the period from 1985 to 2004 the avoidable 
mortality rates fell by 18.9% in Northern 
Territories Aboriginal peoples, by 61% in 
Northern Territories Non-Aboriginal peoples, and 
59% in Australians overall. Aboriginal people 
continue to experience higher avoidable mortality 
and the difference tends to increase over time.  
Most of the decline in avoidable mortality for 
aboriginal people occurred for conditions 
amenable to medical care. 
Schwarz & 
Pamuk (2008) 
Austria 1981 and 
1991 
Identify which causes of 
death contributed most to the 
increase in educational 
inequality in mortality over the 
decade from 1981 to 1991 in 
Austria.  
Basis: Blakely et al (2005) 
- Colorectal cancer, lung 
cancer, IHD, 
cerebrovascular disease, 
diabetes, respiratory 
disease, injury, suicide 
- Age limit 30-74 
Cross-sectional and time 
trend 
Estimation of the slope 
index of inequality (SII) and 
relative index of inequality 
(RII) for overall mortality 
and by cause. 
Among men, increasing education-related 
disparity in deaths from ischemic heart disease 
was the major contributor to the change in 
disparity in overall mortality. Without this 
increase, mortality disparity would have declined. 
In women, increasing education-related disparity 
in deaths from ischemic heart disease also 
contributed most to the slight increase in 
absolute inequality in overall mortality, but 
diabetes and colorectal cancer also contributed 
significantly. In relative terms, there were striking 
increases in disparity for deaths from colorectal 
cancer and digestive diseases among men, and 
for diabetes deaths among women.  
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Author(s) Country/ 
region 
Time period Topic/aim of study Number of causes Design/method Results 
James, Wilkins, 
et al. (2007) 
Canada 1971, 1986, 
1991, 1996 
Examine the income related 
differences in avoidable 
mortality over a 25 year 
period after the establishment 
of universal insurance for 
doctors and hospital services 
in Canada (metropolitan 
neighborhoods). 
µ$YRLGDEOH¶PRUWDOLW\
conditions amenable to 
medical care and health 
policies. 
Basis: previous literature 
- 41 condition amenable to 
medical care plus IHD 
analysed separately,  plus 6 
conditions amenable to 
health policies. 
- Age limit 0-74 (IHD, 
hypertension and 
cerebrovascular disease 
35-74, intestinal infection, 
whooping cough, leukemia 
0-14, measles and acute 
respiratory infections 1-14, 
breast cancer 25-74, 
cervical and uterine cancer 
15-74, diabetes and asthma 
0-49). 
Time trend 
Changes in age-
standardized expected 
years of life lost (SEYLL) 
from causes amenable to 
medical care and health 
policies between the 1st 
and 5th income quintiles 
over the 25 year period. 
Differences between the richest and poorest 
quintiles in age-standardised expected years of 
life lost amenable to medical care decreased 
60% in men and 78% in women; those amenable 
to public health increased 0.7% in men and 20% 
in women; those lost from ischaemic heart 
disease decreased 58% in men and 38% in 
women, and from other causes decreased 15% 
in men and 9% in women. Changes for deaths 
amenable to medical care were significantly 
larger than those for deaths amenable to public 
health or other causes for both men and women. 
 
Stirbu et al. 
(2006) 
Netherlands 1995-2000 Investigate the association 
between avoidable mortality 
and ethnic origin and analyse 
the role of socio-economic 
and demographic factors in 
the association and the 
influence of the duration of 
residence in the Netherlands 
on the risk of death from 
µDYRLGDEOH¶FRQGLWLRQV 
µ$YRLGDEOH´PRUWDOLW\
treatable conditions. 
Basis: Tobias and Jackson 
(2001) 
- 24 conditions plus 
HIV/AIDS and suicides 
- Age limit 0-74, childhood 
infections are excluded 
Cross-sectional 
Poisson regression with 
age-standardized mortality 
rates to estimate relative 
risk by ethnicity (with and 
without controls for socio-
economic and demographic 
characteristics). 
Found slightly elevated risk in total 'avoidable' 
mortality for migrant populations. Higher risks of 
death among migrants were observed from 
almost all infectious diseases and several 
chronic conditions including asthma, diabetes 
and cerebrovascular disorders. Migrant women 
experienced a higher risk of death from 
maternity-related conditions. Surinamese and 
Antillean/Aruban population had a higher 
mortality risk, while Turkish and Moroccans 
experienced a lower risk of death from all 
'avoidable' conditions compared to native Dutch. 
Control for demographic and socioeconomic 
factors explained a substantial part of ethnic 
differences in 'avoidable' mortality. 
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Author(s) Country/ 
region 
Time period Topic/aim of study Number of causes Design/method Results 
Tobias & Yeh 
(2007) 
New Zealand 2000-2002 Quantify the contribution of 
healthcare to ethnic and 
socio-economic inequalities in 
health in New Zealand. 
µ$PHQDEOH¶WUHDWDEOH
mortality  
Basis: Page et al. (2006) 
- 27 conditions 
- Age limit 0-74 (asthma 0-
44) 
Cross-sectional and time 
trend 
Age standardized mortality 
rates by sex from amenable 
causes is compared to the 
same measure from all 
causes and serves as a 
measure of the contribution 
of health system to the 
population health. Similar 
procedure is performed for 
different ethnic groups to 
arrive at a measure of 
health inequality. 
Afterwards, both 
approaches are combined 
to find the contribution of 
healthcare to changes in 
health inequality. 
Amenable causes of death account for 27%, 
34%, 33% and 44% of the total mortality 
disparity for Maori males, Maori females, Pacific 
males and Pacific females, respectively. 
Tobias & Yeh 
(2009) 
New Zealand 1981-2004 Estimate the contribution of 
healthcare to health gain, and 
to ethnic and socio-economic 
health inequalities. 
µ$PHQDEOH¶WUHDWDEOH
mortality 
Basis: Page et al. (2006) 
- 28 conditions 
- Age limit 1-74 (asthma 0-
44) 
Cross-sectional and time-
trend  
Time difference in age 
standardized mortality rates 
by sex from amenable 
causes is compared to the 
same measure from all 
causes and serves as a 
measure of the contribution 
of health system to the 
population health. Similar 
procedure is performed for 
different ethnic groups to 
arrive at a measure of 
health inequality. 
Afterwards, both 
approaches are combined 
to find the contribution of 
healthcare to changes in 
health inequality. 
Approximately one third of the fall in mortality 
over the last quarter of the 20th century is 
accounted for by the fall in amenable mortality 
(implies only treatable causes) for the population 
as a whole, for all income groups and ethnic 
groups, except for Pacific people (no decline in 
amenable mortality) 
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Author(s) Country/ 
region 
Time period Topic/aim of study Number of causes Design/method Results 
Strand & 
Tverdal (2004) 
Norway 
(Oppland, 
Sogn og 
Fjordane, 
and 
Finnmark 
counties) 
1974-78, 
2000 
Investigate the degree to 
which smoking, physical 
activity, marital status, BMI, 
blood pressure, and 
cholesterol explain the 
association between 
educational level and 
ischaemic heart disease 
(IHD) mortality and other 
forms of cardiovascular 
mortality, with main focus on 
IHD mortality 
 
- IHD 
- Age limit 35-49 years old 
in 1974-78 
Cross-section 
Estimation of relative risk 
(RR) using Cox regression 
with adjustments for various 
IHD related risk factors 
IHD mortality risk was higher for people with low 
education compared with people with high 
education. Further, people with low education 
had also more adverse risk factors. Adjustment 
for smoking, physical activity, marital status, BMI, 
blood pressure, and cholesterol reduced the 
relative risks from 1.44 to 1.03 for men and from 
1.91 to 1.24 for women. 
Dahl, Hofoss, et 
al. (2007) 
Norway 1994-1999 Analyse socio-economic 
inequalities in avoidable 
deaths. 
µ$YRLGDEOH¶FRQGLWLRQVDUH
divided into conditions 
amenable to medical care, 
conditions responsive to 
population-based health 
policies, and IHD 
Basis: Korda and Butler 
(2006) (NM 2004), only 
conditions applicable to 
adults 25 and older 
- 29 conditions (Medical 
Care Indicators) plus IHD 
treated separately, plus 3 
Health Policy Indicators 
- Age limit 25-67 years 
Cross-sectional 
Age-standardized mortality 
rates, multiple logistic 
regression analysis 
controlling for age, marital 
status, immigrant status, 
disability pension, 
unemployment, and 
equivalised household 
income. 
Adjusted for sociodemographic and 
socioeconomic factors, education forms a 
marked and independent gradient in overall and 
non-avoidable mortality. With respect to the 
gradient in avoidable mortality it is the same as 
in the overall moratlity for women and is 
somewhat larger for men. Analysis by categories 
of avoidable mortality reveals for men the 
steepest gradient in mortality from preventable 
causes and for women from IHD. The gradient in 
mortality from treatable causes is even flatter 
than from non-avoidable causes.  
Hem, Naes, et 
al. (2007) 
Norway 1990-2001 Investigate if there are 
educational inequalities in 
causes of death considered 
amenable to healthcare in 
Norway and compare this 
with non-amenable causes.  
Avoidable mortality: deaths 
amenable to healthcare 
Basis: Nolte and 
McKee(2004) 
- 33 conditions (plus IHD) 
- Age limit 25-49 and 50-
74 
Cross-sectional 
Cox hazard model to 
estimate the association 
between education and 
mortality adjusting for age 
separately for men and 
women. 
Educational differences in amenable mortality 
from causes of death amenable to healthcare 
are significant in both age groups and sexes. 
This was seen both when including and 
excluding IHD. The effect sizes were comparable 
for amenable and non-amenable causes in both 
age groups and sexes, indicating that the 
healthcare system has no impact on the 
differences in avoidable mortality. 
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Author(s) Country/ 
region 
Time period Topic/aim of study Number of causes Design/method Results 
Strand & Kunst 
(2007) 
Norway  1970, 1990, 
1990-2000 
Describe the association 
between childhood socio-
economic position measures 
(parents; education, 
occupation, and income) and 
mortality, for both genders, 
and assess to what extent 
this association is mediated 
by adult socio-economic 
position. 
- IHD, breast cancer 
- Age limit 25-45 
Cross-sectional 
Estimation of relative risk 
(RR) using Cox regression 
with adjustments for adult 
socio-economic factors. 
Childhood socio-economic position has a strong 
association with mortality from IHD, but not from 
breast cancer. There is a significant mediation 
effect for both men and women of the adult 
socio-economic position with respect to the 
childhood socio-economic position gradient.  
Bautista, 
Alfonso, et al. 
(2005) 
Spain 1998-2000 Study the associations 
between avoidable mortality 
and socio-economic factors in 
a matched case-control study. 
µ$YRLGDEOH¶PRUWDOLW\GHDWKV
from causes amenable to 
medical care. 
Basis: Holland (1988) 
- 18 medical care 
indicators 
- Age limit 5-64 (uterine 
cancer 15-64, all respiratory 
disease 1-14, hypertension 
and cerebrovascular 
disease 35-64, whooping 
cough 0-14, tetanus 0-64, 
osteomyelitis and periostitis 
1-64, maternal ± All, 
perinatal - < 1 week) 
Cross-sectional 
Conditional logistic 
regression for matched 
cases. The match is based 
on medical care indicators 
and age from hospital 
discharge data. 
82 cases of death from avoidable causes were 
compared to 300 controls matched on medical 
care indicators and age. The variables that 
showed a statistically significant association with 
in-hospital avoidable mortality were number of 
diagnoses (the greater the number, the higher 
the risk), length of stay (patients staying seven or 
more days presented a lower risk), and 
education. Those patients with low and middle 
educational levels showed a greater risk of 
avoidable mortality (adjusted odds ratio 3.57 and 
2.82 respectively) than those patients with higher 
levels of education. 
Nolasco,  
Melchor, et al. 
(2009) 
 Spain 
(Alicante, 
Castellon, 
Valencia) 
1996-2003 Describe the inequalities 
observed in preventable 
avoidable mortality (from 
selected causes) with respect 
to socio-economic status in 
small urban areas and 
analyse the changes in these 
inequalities over time. 
µ$YRLGDEOH¶PRUWDOLW\
preventable avoidable 
mortality. 
Basis: Nolte and McKee 
(2004): 
- 4 conditions: malignant 
tumor of the trachea, 
bronchus and lung, 
cirrhosis and other chronic 
disease of the liver, motor 
vehicle accidents and AIDS; 
- Age limit 0-74 
Cross-sectional and time 
trend 
Age-standardized mortality 
rate using the European 
population as a standard by 
sex and Census Tract. 
Poisson regression to 
estimate the relative risk of 
death by socio-economic 
status, controlling for age 
and time trend. Each cause 
of death is analysed 
separately. 
The analysis reveals inverse relationship 
between socio-economic status and risk of death 
from the four specified preventable avoidable 
causes for men but not for women. In terms of 
specific causes, AIDS shows the greatest 
differences in mortality between the lowest and 
highest SES groups. 
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Author(s) Country/ 
region 
Time period Topic/aim of study Number of causes Design/method Results 
Hjern, 
Vinnerljung, & 
Lindblad (2004) 
Sweden 1991-2000 Compare rates of avoidable 
mortality in adolescence 
among child welfare 
recipients and inter-country 
adoptees with the general 
population. 
µ$YRLGDEOH¶PRUWDOLW\VHOHFWHG
causes of death amenable to 
medical care interventions 
and health policies. 
Basis: Rutstein et al. (1976) 
and Charlton et al. (1986) 
- 6 medical care indicators 
and 4 health policy 
indicators 
- Age limit: Adolescence 
(13-27) 
Cross-sectional 
Multivariate analyses with 
Cox regressions of 
proportional hazards of time 
to event with the outcomes 
defined as avoidable 
mortality. 
Intercountry adoptees had a high sex and age 
adjusted relative risk for suicide death only in 
comparison with the general population, while foster 
children and adolescents who had received other 
kinds of child welfare interventions had high sex and 
age adjusted relative risk for suicide death, as well as 
for other avoidable deaths. The relative risk of 
avoidable deaths for foster children and other child 
welfare recipients decreased considerably when 
compared with youth brought up in homes with 
similar psychosocial characteristics as their original 
home. 
Grant, Munoz-
Arroyo, et al. 
(2006) 
UK 
(Scotland) 
1981-2004 Study the time-trends and 
regional differences in 
avoidable mortality across 
Scottish regions. 
µ$YRLGDEOH¶PRUWDOLW\GHDWKV
amenable to medical care. 
Basis: Nolte and McKee 
(2004)  
- 33 treatable conditions 
and IHD 
- Age limit 0-74 (intestinal 
infectious disease, 
whooping cough 0-14, 
respiratory disease (excl. 
pneumonia and influenza) 
1-14, uterine cancer, 
leukemia 0-44, diabetes 0-
50, misadventures to 
patients during surgical and 
medical care, maternal 
deaths  ± All) 
Cross-sectional and time 
trend 
Regional differences in age 
standardized mortality 
rates, comparison of overall 
Scottish time trend in 
avoidable mortality to 
selected EU countries. 
Age and sex standardized amenable mortality 
rate for the period 1981 to 2004 show 
considerable variation across Scotland. 
Descriptive analysis points to the existence of a 
gradient between deprivation and avoidable 
mortality. More deprived areas observe higher 
avoidable mortality. A comparison between 
Scotland and selected countries in the European 
Union shows that compared to the UK, France, 
Italy, Portugal, Austria and Spain, Scotland had 
higher avoidable mortality rates over the period 
1980-1998 for both males and females. 
However, the difference has decline over time. 
 
Macinko & Elo 
(2009) 
USA 1980-2005 Analyse black-white 
differences in avoidable 
mortality and their 
development over time. 
µ$YRLGDEOHPRUWDOLW\¶LQIRXU
categories: conditions (1) 
amenable to medical care, (2) 
sensitive to public health 
policies, (3) IHD, (4) 
HIV/AIDS. 
Basis: Nolte and McKee 
(2004) 
- 34 conditions (Medical 
Care Indicators) plus IHD 
treated separately plus 
HIV/AIDS, plus 3 Health 
Policy Indicators 
- Age limit 0-64, since 
black male life expectancy 
in 1980 was 64 years. 
Time trends 
Age standardized mortality 
rates by sex and race and 
cause of death, negative 
binomial regression model 
to estimate relative mortality 
risk for black people versus 
white people. 
In 2005, medical care amenable mortality was the 
largest source of absolute black-white mortality 
difference, contributing 30% of the difference in all-
cause mortality among men and 42% among 
women. Avoidable mortality from causes sensitive to 
public health policies contributed 20% of the 
difference for men and 4% for women. Although 
absolute black-white disparities for most conditions 
diminished over time, relative disparities as 
measured by rate ratios changed little, except for 
HIV/AIDS for which relative risks increased 
substantially for both black men and women. 
Avoidable mortality: what it means and how it is measured  31 
 
 
Table A4: Empirical studies of avoidable mortality ± analyses of changes over time (2004 onwards) 
Author(s) Country/ 
region 
Time period Topic/aim of study Number of causes Design/method Results 
Korda & Butler 
(2006) 
Australia 1968-2001 Investigate the time trend in 
avoidable mortality on 
Australia over the period 
1968-2001 and compare the 
country to other 10 EU 
countries. 
µ$YRLGDEOH¶PRUWDOLW\FDXVHV
amenable to medical care; 
causes mainly responsive to 
health policy, and IHD. 
 
Basis: Nolte and McKee 
(2004) 
- 34 conditions (Medical 
Care Indicators) plus IHD 
treated separately, plus 3 
Health Policy Indicators 
- Age limit 0-74  
Time-trend 
Age standardized mortality 
rates by sex, comparison to 
10 EU countries from NM 
(2004) and ranking. 
Total avoidable death rates fell by 68% in 
females and 72% in males. The corresponding 
non-avoidable death rates fell by 35 and 33%. 
The annual declines were 3.47% in males and 
3.89% in females in avoidable mortality rates 
and 1.09% and 0.95% respectively for non-
avoidable mortality. In females, declines in death 
rates from causes amenable to medical care 
contributed 54% to the decline in avoidable 
mortality rates, ischaemic heart disease 
contributed 45% per cent, and causes 
responsive to health policy intervention 
contributed one per cent. In males, the 
corresponding contributions were 32%, 57% and 
11% respectively. These rates, and the declines 
between 1980 and 1998, were comparable with 
selected European countries, with Australia's 
ranking improving over the period. 
Burcin (2009) Czech 
Republic 
1990±2006 Evaluate the contributions of 
avoidable mortality categories 
in different age groups to the 
change in temporary life 
expectancy (ages 0-74) 
between 1990 and 2006. 
µ$YRLGDEOH¶PRUWDOLW\FDXVHV
both treatable and 
preventable, and IHD. 
Basis: Nolte and McKee 
(2004) and Newey et al. 
(2004) 
- 33 treatable conditions, 3 
preventable and IHD 
- Age limit 0-74 (intestinal 
infectious disease, 
pertussis, measles 0-14, 
respiratory disease (excl. 
pneumonia and influenza) 
1-14, uterine cancer, 
leukemia 0-44, diabetes 0-
49) 
Time-trend 
Age and sex standardized 
mortality rates are used to 
decompose temporary life 
expectancy changes over 
the period. 
Observed decline in avoidable mortality among 
males in the Czech Republic was almost 40% 
and among females almost 38%, whilst the 
decrease in unavoidable mortality was 21% and 
24%, respectively. The observed decline in 
avoidable mortality contributed significantly 
(among males 75% and among females 68%) to 
the total increase in average life expectancy 
expressed as temporary life expectancy between 
the ages of 0 and 75. 
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Author(s) Country/ 
region 
Time period Topic/aim of study Number of causes Design/method Results 
Luran, Lopes et 
al (2009)(in 
Spanish) 
Colombia 1985-2004 Assess trends in avoidable 
mortality of preschool children 
in Colombia 
Basis: Taucher (1979) 
- 46 conditions 
- Age limit <1 year, 1-4 
years 
Time trend 
Calculation of percentages 
of mortality due to 
DYRLGDEOHFRQGLWLRQV¶ 
In children aged less than one, the avoidable 
mortality accounted for more than 50% of 
recorded deaths. In children aged 1 to 4 - 40% of 
recorded deaths-deaths due mainly to 
respiratory diseases. Over the 20-year period, 
the avoidable mortality rate decreased by 34% in 
children aged less than one, and by 23% in 
children 1-4  
Logminiene, 
Nolte et al. 
(2004) 
Lithuania 1991-1999 
compared to 
1970-1990 
&RPSDUHWUHQGVLQµDYRLGDEOH
PRUWDOLW\¶ (separately 
preventable and treatable) 
over two periods of time. 
µ$YRLGDEOH¶PRUWDOLW\FDXVHV
of death amenable to 
KHDOWKFDUHµWUHDWDEOH¶DQG
causes of death amenable to 
broader health policy 
µSUHYHQWDEOH¶ 
Basis: Holland (1997) 
- 14 conditions: 11 
treatable and 3 preventable 
- Ages 5-64 for 
comparability; cervical 
cancer 15-64, rheumatic 
heart disease and asthma 
5-44, respiratory disease 1-
14, hypertens./cerebrovasc. 
35-64, maternal deaths all 
years,liver cirrhosis 15-64.  
Time trend 
Age standardized death 
rates using European 
Standard Population, 
graphical analysis of AM as 
a whole and by particular 
causes. 
Avoidable mortality declined as a proportion of 
total mortality in Lithuania during 1991-1999 
compared with 1970-1990 in spite of some initial 
rise in death rates from treatable and 
preventable causes in early 90s. 
In 1970-1990, avoidable causes of death 
accounted for 26.3% of all deaths. By 1991-1999 
this figure had decreased slightly to 24.6%. At 
the same time, age-standardised death rates 
from avoidable causes increased by 8%. 
Avoidable mortality among men was 
considerably higher than for women in both 
periods. Increases were registered for death 
rates from tuberculosis, cervical cancer and liver 
cirrhosis and, immediately after the 
independence, also from hypertensive and 
cerebrovascular diseases and, among men, from 
lung cancer. This has, however, declined with 
time. Deaths from chronic rheumatic heart 
disease, asthma and other respiratory diseases, 
appendicitis, abdominal hernia, cholelithiasis and 
maternal mortality declined continuously over 
time. 
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Author(s) Country/ 
region 
Time period Topic/aim of study Number of causes Design/method Results 
Nante et al. 
(2005) 
Italy 
(Liguria 
region) 
1990-1992 
and 1996-
1998 
Analyse life expectancy at 
birth and avoidable mortality 
in the region and compare it 
to the rest of Italy. 
µ$YRLGDEOHPRUWDOLW\¶IURP
selected causes of death 
ZKLFKFRXOGEHDYRLGHG³ZLWK
SULPDU\SUHYHQWLRQ´³ZLWK
early diagnosis and 
LQWHUYHQWLRQ´³ZLWKDGHTXDte 
diagnostic and therapeutic 
KRVSLWDOVHUYLFHV´³ZLWK
KHDOWKVHUYLFHV´ 
Basis: Prometeo (2001) 
study 
- 4 conditions (MCI) plus 4 
(Primary Prevention), 
analysed separately 
- Age limit 5-69 years 
Time trend 
Age standardized mortality 
rates by sex and cause of 
death. 
Compared to the rest of Italy, the Liguria region 
has generally low rates of avoidable mortality 
with the exception of AIDS (province of Genoa) 
and uterus cancer (province of Imperia). 
Gispert, Serra, 
et al. (2008) 
Spain 1987-2001 Evaluate the impact of 
avoidable mortality on 
changes in life expectancy at 
birth. 
µ$YRLGDEOH¶PRUWDOLW\GHDWKV
from causes amenable to 
health services and health 
policies. 
Basis: Gispert et al. (2006) 
- 27 conditions avoidable 
by health service 
interventions plus 6 health 
policy indicators; 
- Age rage 0-74 (cervical 
and uterine cancer 15-74, 
asthma 5-49, IHD 35-74, 
diabetes 0-49, leukemia 0-
14, alcoholic live disease 
15-74, maternal mortality, 
perinatal conditions, 
adverse effects during 
surgical and medical 
procedures. AIDS/HIV, 
traffic accidents, suicide, 
homicide ± all ages) 
Time trend 
Decomposition of changes 
in life expectancy using the 
method developed by 
Arriaga (1984). 
Life expectancy increased in all ages and both 
sexes primarily due to reductions in mortality 
amenable to health policy interventions. The 
highest improvement in LE was due to non-
avoidable causes, but avoidable mortality 
through health service interventions showed 
improvements in LE in those younger than 1 
year and in those aged 45-75 years. 
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Author(s) Country/ 
region 
Time period Topic/aim of study Number of causes Design/method Results 
Chung, Song, 
et al. (2008) 
South 
Korea 
1983-2004 Evaluate the achievement of 
healthcare services by 
observing the time trend of 
avoidable death between 
1983 and 2004.  
µ$YRLGDEOH¶PRUWDOLW\GHDWKV
amenable to medical care, 
secondary prevention and 
primary prevention (health 
policy indicators). 
Basis: Holland (1993) 
32 conditions (Medical Care 
Indicators and Health Policy 
Indicators) 
Age limit 1-64, maternal 
deaths 15-64 
Time trend  
Age standardized mortality 
rates by age groups and 
sex. 
The avoidable mortality rate (per 100,000 
persons) decreased from 225 to 84 in men and 
from 122 to 41 in women. Accordingly, the 
proportion of avoidable deaths among all 
classifiable deaths was reduced by 8.1% in men 
and 6.4% in women. However, mortality rates 
from some preventable causes such as IHD and 
malignant neoplasms of lung, breast, cervix, and 
colorectum have been on the rise. Mortality 
preventable by appropriate medical care showed 
the greatest reduction (by 77.8%), while mortality 
preventable by primary prevention showed the 
least reduction (by 50%). 
Wheller et al. 
(2007) 
UK 
(England 
and 
Wales) 
1993-2005 To analyse recent trends in 
avoidable mortality using lists 
of avoidable causes by NM 
(2004) and Page, Tobias et al 
(2006) and discuss options 
for the development of the 
National statistics of 
avoidable mortality. 
µ$YRLGDEOHPRUWDOLW\¶FDXVHV
of deaths which can be 
avoided through healthcare 
interventions (NM 2004), 
same plus conditions 
sensitive to public health 
policies (Page, Tobias et al. 
2006). 
Basis:  
- Nolte and McKee 2004 
(34 conditions) 
- Page et al. 2006 (28 
amenable to healthcare 
plus 22 preventable) 
- Age limit 0- 74  
Time trend 
Directly age-standardized 
mortality rates, 
standardized years of life 
lost due to avoidable 
causes. 
 
Levels of avoidable mortality between 1993 and 
2005 decreased by 43-46% for males and 38-
41% for females depending on the list of 
conditions used. Mortality from preventable 
causes decreased by 18% for males and 8% for 
females (Page et. al list). Mortality from all 
causes not considered avoidable decreased by 
9-14% and 5-8% for males and females 
respectively. 
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